The Thousand Faces of Malignant Melanoma: A Systematic Review of the Primary Malignant Melanoma of the Esophagus

Abstract

Simple Summary

Primary malignant melanoma of the esophagus (PMME) represents a fairly described and represented entity in the literature, although only in the middle of the last century was it recognized as actually existing. In this systematic review we address the history of PMME starting from 1906, the year in which Bauer made the first description of this entity, passing through his first demonstration on an autopsy series by De Pava et al. and we come to the most recent notions of molecular biology and immunotherapy.

Abstract

Primary Malignant Melanoma of the Esophagus (PMME) is an extremely rare cancer of the esophagus, accounting for 0.1–0.8% of all oro-esophageal cancers and <0.05% of all melanoma subtypes, with an estimated incidence of 0.0036 cases per million/year. We conduct a careful analysis of the literature starting from 1906 to the beginning of 2022, searching the PubMed, Science.gov, Scopus and Web of Science (WoS) databases. A total of 457 records were initially identified in the literature search, of which 17 were duplicates. After screening for eligibility and inclusion criteria, 303 publications were ultimately included, related to 347 patients with PMME. PMME represents a very rare entity whose very existence has been the subject of debate for a long time. Over time, an increasing number of cases have been reported in the literature, leading to an increase in knowledge and laying the foundations for a discussion on the treatment of this pathology, which still remains largely represented by surgery. In recent times, the possibility of discovering greater mutations in gene hotspots has made it possible to develop new therapeutic strategies of which nivolumab is an example. Future studies with large case series, with clinicopathological and molecular data, will be necessary to improve the outcome of patients with PMME.

1. Introduction

Primary Malignant Melanoma of the Esophagus (PMME) is an extremely rare cancer of the esophagus, described for the first time by Bauer in 1906 [1] accounting for 0.1–0.8% of all oro-esophageal cancers and <0.05% of all melanoma subtypes [2,3] with an estimated incidence of 0.0036 cases per million/year [4]. Between the report of the first case and 2021, 347 cases of PMME were reported. PMME constitutes 5.6% of all gastrointestinal (GI) tract melanomas. Although PMME is a rare subtype of esophageal cancer, it has been relatively well reviewed. PMME is a highly aggressive tumor that is associated with a poor prognosis, with a 5-year overall survival (OS) rate of <5% [5,6]. The debate on its genesis starting from the esophagus has been quite heated since it was not believed at the time of the first descriptions that there could be melanocyte cells at the esophageal mucosal level [4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19], and only with the first autoptic series did it begin to prove in a clear way that melanoma could also originate from this part of the body [20]. From a topographical point of view, 90% of PMME cases involve the middle/distal third of the esophagus, which is usually solitary, but in about 13% of cases it presents with multiple lesions. Macroscopically, these are intra-luminal polypoid lesions, capable of obstructing the esophageal lumen in a variable degree percentage, with symptoms related to the degree of stenosis. In more than 85% of cases, PMME presents as a hyperpigmented lesion, and in the remaining 15% of cases it presents as amelanotic. One of the most important differential diagnoses is with esophageal melanosis (or melanocytosis), which would represent a pre-neoplastic lesion for some authors [20,21,22,23,24,25,26].

In this paper, we conduct a careful analysis of the literature starting from 1906, the year in which Bauer described a case of PMME for the first time, and we arrive at the beginning of 2022, focusing on the new therapeutic strategies of the latest generation, such as immunotherapy, trying to designate future perspectives on the treatment of this entity.

2. Materials and Methods

A systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Indeed, a search of the PubMed, Science.gov (accessed on 17 July 2022), Scopus and Web of Science (WoS) databases was performed for the period 1906–2022 using the following terms: Primary or Primitive Malignant Melanoma or Melanoma in combination with each of the following: Esophagus, Oesophagus, Mucosal. The last search was run on 8 May 2022. Only manuscripts reporting certain cases of primitivity of melanoma in the esophagus were included. Articles with uncertainty about primitiveness or whose metastasis to the esophagus could not be ruled out were not considered. Review articles with/without meta-analyses, observational studies and case reports were all included, without language distinction. Other potentially relevant articles were identified by manually checking the references of the included literature.

An independent extraction of articles was performed by two investigators (G.C. and K.M.) according to the inclusion criteria. Disagreement was resolved by discussion between the two review authors.

3. Results

A total of 457 records were initially identified in the literature search, of which 17 were duplicates. After screening for eligibility and inclusion criteria, 303 publications were ultimately included (Figure 1). The majority of publications were case reports (n = 273), followed by review (n = 13), case series (n = 5), observational prospective studies (n = 4), letters or editorial (n = 6) and comparative studies (n = 2). A total of 347 patients’ PMMEs were recorded.

The most common symptoms were dysphagia (75%), retrosternal pain (69%), difficulty swallowing solids and liquids (51%) and, in the most advanced cases, weight loss and digestive difficulties, along with more rare melena and hypovolemic shock. The median survival, according to the various authors, was estimated from 2 to 5% at 5 years, with a median survival of 10 months. A total of 90% of cases involved the middle and distal thirds of the esophagus; in 88% of cases it was a solitary lesion, but in the remaining 12% of cases, multiple lesions were reported. Macroscopically, these lesions were usually intra-luminal polypoids with variable obstruction of the esophageal lumen. In 85% of cases, they turned out to be pigmented, with about 15% being amelanotic. From the works included in these reviews, it appears that the main differential diagnoses are represented by esophageal melanocytosis, both from a macroscopic/endoscopic point of view and a histopathological point of view. In most of the reported cases, PMME involved the mucosal and submucosal plane, with frequent radial growth and frequent invasion of the lympho-vascular space. In about half of the cases analyzed (50%), the disease was already metastatic to other organs, represented (in decreasing order of frequency) by: liver, mediastinum, lung and brain.

4. Discussion

Although a rare entity and considered anecdotal for a long time, PMME has been studied and described over the decades, with different levels of description ranging from single case reports of “pigmented” lesions in correspondence with the esophageal mucosa, up to actual studies of clinicopathological and molecular characterization of this primary esophageal neoplasm [4,5,6]. In 1952, Garfinkle J. M. et al. reported the first case with histological correlation described in the literature. In fact, the previously reported cases had only been illustrated from a clinical point of view, with no real demonstration of malignant melanocytic neoplasm. In this paper, the authors described a pigmented lesion of the esophageal mucosa of a 55-year-old woman, on which biopsies suggesting a melanocytic nevus were taken. Only subsequently did the morphological finding indicate a malignant melanoma [7]. In the following years, other authors [8,9,10,12,13,14,15,16,17,18,19] reported their experience with suspected or presumed cases of PMME, even if the number of cases that could actually be considered primitive of the esophagus were even more limited than those published until then, as the Allen–Spitz diagnostic criteria [11] restricted the effective number of PMMEs to: (1) typical histologic pattern of melanoma with the presence of melanin granules within the tumor cells; (2) origin in an area of junctional change within the squamous epithelium; (3) junctional activity with melanotic cells in the adjacent epithelium). In 1957, with the paper by Keeley et al. [12], this entity began to be defined as malignant melanoma of the esophagus and not with terms such as “melanocarcinoma” or “melanosarcoma” or “nevocarcinoma” or “melanoblastoma” of the esophagus [13,14,15,16,17,18,19,20,21,22,23,24,26,27,28,29].

In 1963, de la Pava et al. [20] showed the presence of melanocytes in the esophageal epithelium in four out of 100 normal esophagi from autopsied materials and only from this moment was the actual existence of PMME officially recognized.

In 1970, Piccone et al. published an interesting case report concerning a patient, a 70-year-old man, with a primary melanosis of the esophagus and in whom a PMME had developed. The authors reported that this was the fourth case in the literature of a patient with melanosis of the entire esophagus and supported their hypothesis of an origin in the context of esophageal melanosis, studying the different pigmented lesions affecting the subject [25]. In 1972, Frable et al. reported one of the first electron microscopy studies performed on PMME tissue. Cancer cells contained membrane-bound dense material consistent with melanin and a rare pre-melanosome. The latter structure was not typical, lacking the usual crystalline pattern or cross-linking. This last structure was interpreted by the authors as a stage in the development of melanin, closer to the mature product [30]. These types of studies have been fundamental to understanding, over time, if and how it was acceptable to assert a primitive origin of a malignant melanoma starting from the esophagus.

Over the years, PMEE reports have multiplied [26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82], and, in 1983, Aldovini et al. [56] reported their experience with a 54-year-old male patient with a PMME on which a brushing cytology had been performed, which revealed atypical cells with melanin granules that tested positive with the Fontana–Masson method. In this paper, we can glimpse the growing certainty of the real existence of PMEE, considering that around the brownish neoplastic mass, the presence of irregular pigmentation (corresponding to junctional snow lesion) was observed. In 1990, Taniyama et al. [83] described a very rare case of amelanotic PMEE in a 76-year-old patient with a polypoid lesion with an irregular, whitish surface, located in the intrathoracic middle third of the esophagus. The authors discussed the possible difficulties in recognizing this type of melanic lesion without pigment and stressed the need to: (1) carefully search for possible lesion components at the dermal-epidermal junction and (2) perform appropriate immunohistochemical investigations to demonstrate the melanocytic nature of the lesion component. Regarding the epidemiology of PMEE, in a 1990 paper by Aagaard et al. [84], a single center experience of 25 years related to primary non-epithelial malignant tumors of the esophagus was reported. The authors reported on a total of 708 tumors of the thoracic esophagus, and only 4 cases (0.56%) of PMME. In other papers [85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100], Chello et al. [101], in 1993, reported the case of a metastatic PMME to the walls of the left atrium of the heart in a 75-year-old patient with massive pericardial effusion. The authors of the article stressed the importance of excluding metastatic disease in subjects with melanoma, meeting the now acclaimed Allen–Spitz criteria for a correct diagnosis of PMME, and moreover, stressed the importance of keeping in mind the potential of malignant melanoma to be able to metastasize, sometimes even at the level of the heart. In pursuing this aim, they mentioned Waller et al., who suggested that in a patient with a known history of MM, an acute pericarditis, or sudden pericardial effusion, a second or third degree atrioventricular block, or cardiac tamponade, or also congestive heart failure, healthcare professionals should always suggest excluding the possibility of metastases of melanoma.

Over the next nine years (1993 to 2002), another 50 papers [102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152] reported 62 cases of PMME, with some peculiarities represented, among others, by another case of amelanotic PMME [106] by Loftus et al., and then a case of PMME with a massive hememesis [108] in which it was emphasized that, although rarely, PMME can present itself primarily with a hyperacute symptomatology and that puts the life of the patient in danger. Interestingly, Yano et al. reported the association of a PMME with an adenocarcinoma of the lung for the first time [128]. Equally interesting was the paper by Lam et al., which reported a case of PMME with loss of immunoexpression of p53, going to try to analyze (albeit in an embryonic way) the mechanisms of gene deregulation that are also found during this neoplasm [135].

In 2002, Brown et al. [153] reported the challenging case of a 76-year-old woman who had had dysphagia and retrosternal pain for about three months. The first diagnosis, carried out on biopsy, had suggested the possibility of a PMME, even if the lesion was not easy to classify nosographically. After the following esophagectomy, the sample was studied in detail, and it was realized that more than a PMME, it was a melanotic schwannoma, much rarer than PMME (about 11 cases described up to the time of the article in question) but reasonably related to malignant melanoma from the point of view of differentiation.

After the paper by Holck, Lin and Benferhat et al. [154,155,156], in a paper by Lohmann C. et al. [157] in 2003, a case series of 10 patients (mean age of 64 years) with PMME was presented. Most of the lesions reported were located in the mid-distal esophagus and were large, with a mean tumor size of 6.2 cm at diagnosis and a mean invasion depth of 1.86 cm); furthermore, two melanomas were associated with a large component in situ and about half of the tumors were amelanotic. Histological features were broad, including cases that mimicked lymphoma, poorly differentiated adenocarcinoma or sarcoma. In this study, 7/10 patients had metastatic disease at the time of presentation, and 9/10 patients underwent tumor resection with negative surgical margins. The authors reported a poor survival rate, with a median of 19.8 months. On the other hand, one patient with a tumor limited to the submucosa was still alive 108 months after esophagectomy. A total of 6/10 patients with PMMEs were tested by immunohistochemistry and were positive for all melanocyte differentiation markers; but also were positive for CT antigens, with MA454 being the most commonly found, suggesting that CT antigens could have been a promising immunotherapeutic target for esophageal melanomas.

PMME cases continued to increase in number, reaching about 260 in 2006 [154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176], when Dionigi et al. [177] presented a case of a 62-year-old Caucasian woman who had undergone five years of prior esophagectomy with en-bloc lymphadenectomy for a PMME. At subsequent checks, a chest x-ray revealed a 1.3 cm pulmonary nodule in the upper lobe of the left lung, which, when biopsied, was found to be a metastasis of a previous PMME. The authors, in this paper, stressed the concept of how important it was to perform a continuous follow-up over time for patients with previous PMME and, moreover, they remarked on what was reported by Chalkiadakis et al. [63], indicating a PMME metastasis rate of 78%.

After other reports [178,179,180,181,182,183,184,185,186,187], Fredricks et al. [188] reported an extremely rare case of PMME in a patient with human immunodeficiency virus (HIV) for more than 10 years. Interestingly, the operative esophagectomy specimen had the largest mass represented by the MM, but also two other pigmented lesions that were further away from the largest mass. On histological examination, these lesions resulted from junctional nevus and atypical melanocytic hyperplasia up to melanoma in situ. This case report has been of great importance because it has allowed us to provide a model of local tumorigenesis of PMME starting from dysplastic melanocytic lesions with greater accuracy.

In the following years, various authors continued to report an increasing number of cases of PMME [189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218] and, in 2012, Inadomi et al. described an interesting case of recurrent PMME in a 57-year-old patient who had already undergone subtotal esophagectomy for a PMME and who, five years later, in 2011, had recurrent melanoma at the point of previously conducted esophageal-jejunal anastomosis. This case report proved to be of great help in obtaining follow-up data, which in the case of patients with PMME were almost completely absent, considering that the 5-year survival rate is around 2.2%. Furthermore, another merit of this paper was to highlight the possibility that basic diagnostic instrumental methods, such as esophagoscopy, could not detect the entire extension of the PMME, as in the case of the patient in question, who presented melanocytic lesions atypical far beyond what was found in instrumental diagnostics [219]. These concepts were also analyzed in the next papers by Cardena [220] and Suarez-Aliaga et al. [221], and in a 2013 comparative study, Wang S. et al. presented the clinical data of 13 patients with PMME treated surgically as primary therapy at their center in the time period from 2000 to 2012. The mean age (± standard deviation) was 66.4 ± 7.6 years, and 84.6% were male. Overall, 61.5% of tumors were located in the lower thoracic esophagus. The authors reported surgical morbidity and mortality rates of 7.7% and 53.9%, respectively. The incidence of lymph node metastases for patients with tumors invading the mucosa was 0 but increased to 42.9% with tumors invading the submucosal layer. Furthermore, authors reported that PMME had a different probability to metastasize depending on the topography: for example, tumors localized in the middle third of the esophagus metastasized most frequently to the perigastric lymph nodes than the middle mediastinal lymph nodes. For PMME located in the lower third of the thoracic esophagus, superior mediastinal lymph node metastasis (2 of 4) with invasion of the tumor penetrating the correct muscle layer was more likely. Relapse occurred within 1 year in all patients with post-stage Ib cancer, and the most common recurrent organ was the liver. The 1- and 5-year overall postoperative survival rates were 54.0% and 35.9%, respectively, and lymph node metastases were the independent predictor for postoperative survival [222].

From 2013 to 2016, other 35 cases of PMME were reported in literature [223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253] with a particular emphasis about the case presented by Zhang et al. [228] that measured 12 cm (huge PMME).

In a 2016 paper, Gao S. et al. summarized and analyzed the characteristics of 17 patients with PMME (mean age of 57.5 ± 10.3 years) who had undergone surgical resection in their center. The majority of the patients were male, with smoking and alcohol consumption of 41.2% and 23.5%, respectively. The lymph node metastases in this series mainly involved the medium-lower mediastinal area and the upper abdominal area. PMMEs that invaded beyond the submucosal layer (T2–T4) had a much higher tendency to lymph node metastasis than those limited to the submucosal layer (T1) (6/8, 75.0% vs. 3/9, 33.3%, p = 0.086). The 1- and 5-year survival rates of the patients were 51% and 10%, respectively, with a median survival time of 18.1 months. Survival analysis showed that TNM stage was a predictor for PMME prognosis (median survival time of 47.3 months vs. 8.0 months for stage I/II versus stage III, respectively, p = 0.018) and multivariate Cox regression analysis revealed the independence of its prognostic value [HR (95% CI): 5678 (1125–28,658), p = 0.035] [254].

After other six cases of PMME [255,256,257,258,259,260], Hayian Su et al., in their 2017 work, analyzed 21 cases of PMME at Tianjin Medical University Cancer Institute and Hospital from January 2002 to February 2017. In terms of sintomatology, 19 patients presented with dysphagia and two patients complained of retrosternal pain. From a histological point of view, all tumors were composed of atypical melanocytes with a lot of melanin pigment intra and around the tumor. In this study, OS was 1–40 months, with the median time of 10 months. The mucosal staging classification for the upper aerodigestive tract showed a better distribution of overall survival with different stages than that of the American Joint Commission on Cancer staging classification for esophagus, but without statistical difference. Both the clinical and pathological characteristics were not highly consistent with OS [261].

In this way, after the some other papers [262,263,264], it is important to mention a contribution from Katerji et al. who, again in the same year, presented a case of PMME in an 82-year-old man in which the immunophenotype was aberrant for the CD56 (or NCAM, Neural Cell Adhesion Molecule) marker. The authors, in fact, warned against making a hasty diagnosis as it is the pathologist’s work to know these potentially dangerous pitfalls [265].

It is important to underline that among the PMMEs, a rate of between 15 and 25% is present as amelanotic lesions [83,106,171,172,174,178,194,266,267,268,269,270,271,272,273,274,275]. Kobayashi et al., among other authors, reported a case of amelanotic malignant melanoma of the esophagus in a 68-year-old man previously operated on for the detection of gastric carcinoma. After a few months, following the finding of dysphagia symptoms, the patient underwent esophagoscopy, which revealed a mucosal melanosis adjacent to a protruding lesion in the esophageal lumen. The patient underwent a curative trans-thoraco-abdominal subtotal esophagectomy. Immunohistochemical examination of the excised sample was negative for markers such as HBM-45 and Melan-A but was positive for SOX10 (Sry-related HMg-Box gene 10), KBA.62 and tyrosinase. A primary diagnosis was made of an amelanotic malignant melanoma of the esophagus which consisted only of premelanosomes. The authors’ findings suggest that, in the diagnosis of malignant melanoma, SOX10 and KBA.62 may be useful, particularly in the diagnosis of amelanotic malignant melanoma [271].

Regarding one of the largest cohorts of PMME patients, Wang et al. conducted a retrospective analysis of clinical data from 76 patients at Peking University Cancer Hospital over the period January 2008 to September 2017. The authors assessed objective response rates (ORR) and progression-free survival (PFS). These patients were classified as unresectable or metastatic and were assigned to three cohorts based on the treatment they underwent: chemotherapy (C: 46 patients), targeted therapy (T: 2 patients) and PD-1 inhibitors (IT: 12 patients). In this study, PFS in cohort C was three months with a limited ORR of 10.9%. In the IT cohort, seven patients (75.0%) achieved a partial response and three had stable disease for more than four months. The median PFS in the IT cohort was not reached and the mean was 15.6 months, which was much longer than in cohort C (p < 0.001) [276]. Therefore, these authors renewed the need to employ techniques such as massive gene sequencing to be able to search for biomarkers capable of predicting the response of PMME to anti-PD1 immunocheckpoint inhibitors. After another 38 cases of PMME [274,277,278,279,280,281,282,283,284,285,286,287,288,289], Endo F. et al. [290] reported a case of a 70-year-old man who complained of dysphagia due to the presence of a polypoid lesion in the lower thoracic esophagus. Although the histopathological examination had provided the diagnosis of esophageal squamous carcinoma at first, with subsequent pT3N1M0 staging and clinical stage III, a histological re-evaluation after radical esophagectomy revealed the presence of atypical melanocyte cells positive for S-100 protein, Melan-A and HMB-45, and, therefore, PMME was diagnosed. After 16 months, an abdominal TC revealed a solitary retroperitoneal recurrence in the lateral layer of the ascending colon. FDG-PET imaging showed hypermetabolic accumulation with a SUV value of 5.8. The patient was treated with nivolumab (240 mg) every two weeks and after eight courses of nivolumab, the abnormal accumulation of retroperitoneal mass disappeared on PET scan and this therapeutic effect continued for 20 months.

Data very similar to this was reported by Ito S. et al. [291], who presented a case of an 81-year-old Japanese female presented with a PMME diagnosis histologically established. After the surgery, the patient presented multiple lymph node and bone metastases, and so began treatment with nivolumab 240 mg every two weeks. After eight cycles of nivolumab, both lymph node and bone metastases were markedly reduced. The patient received 30 courses of nivolumab and has maintained the partial response without severe adverse events. These data are very similar to those of the paper of Chu et al. [292].

Very interesting, again in this context, is the case reported by Yamaguchi T. et al. [293], in which the authors describe the so-called “abscopal” effect in a 75-year-old woman with a PMEE of the esophagogastric junction, removed by proximal gastrectomy with resection of the lower esophagus. After three months, the patient complained of left pleural metastases and began nivolumab, but after three courses, the patient exhibited grade 3 renal dysfunction, as a result of which the drug was discontinued. Five months after the development of renal dysfunction, a CT scan showed a non-colored lump within the pancreas and the patient was diagnosed with pancreatic metastasis; intensity modulated radiotherapy was performed. Six months later, CT revealed that the pancreatic nodule and pleural metastases had decreased; after another two months, the pleural metastases and the effusion had disappeared. The patient was alive and in clinical remission.

This paper has the merit to describe a concomitant “synergistic” effect between irradiation (radiotherapy) and the administration of nivolumab, setting a rationale for future studies capable of studying the potential use of both therapeutic modalities.

Surgery has traditionally been the only option for prolonging survival in patients with PMME [146,169,213,235,247,259,294], and total or sub-total esophagectomy appears to offer better survival outcomes. The efficacy of both chemotherapy and radiotherapy have been shown to be limited [166,167,201,218,241,260]. The introduction of immunotherapy, particularly programmed death 1 (PD-1) inhibitors such as nivolumab and pembrolizumab, together with the cytotoxic T-cell-associated antigen 4 inhibitor (CTLA4) such as ipilimumab in combination with nivolumab, significantly extended overall survival in metastatic melanoma. Indeed, ICI is currently positioned as a first-line therapy for melanoma without BRAF mutations, and the 3-year overall survival rates have reached 51%, 40% and 56%, respectively [295].

Although Nivolumab has been shown to be less effective in mucosal melanomas than in cutaneous melanomas, the standard treatment and efficacy of ICI in PMME remain unclear due to its rarity [275,288,289,290,291,292,293,296,297,298,299,300,301,302,303,304]. As we have analyzed, some studies have revealed promising results, but there is a need for randomized controlled trials with larger series of PMME patients [186,218,275,305].

Table 1 summarizes PFS and OS in the studies published so far regarding the use of ICI in PMME.

In recent years, the greater diffusion of molecular biology techniques such as next generation sequence (NGS) and parallel massive sequencing have made it possible to deepen the knowledge related to PMME by analyzing the different mutations responsible for this entity [275,289,291,292,293,296,297,298,299,300,301,302,303]. More specifically, in a very recent work, Tsuyama et al. studied 13 cases of PMME and 10 cases of malignant skin melanoma (SKMM) with NGS and immunohistochemistry. NGS analysis based on DNA and RNA hybridization capture revealed that NF1 was the most frequently mutated gene, but other mutations detected were SF3B1, KRAS, BRCA2, KIT and TP53.

Furthermore, the authors indicated that the common BRAF mutation (present in cutaneous malignant melanoma) was not present in the analyzed cases of PMME. It was also agreed that a subset of PMME may contain viable mutations. Furthermore, the authors reported that response rates to immunotherapy were lower in this patient cohort [304]. Finally, immunohistochemistry results and mutation status were concordant between p53/c-Kit and TP53/KIT, with a focal expression of PD1 observed in a single PMME sample. The burden of tumor mutations in PMME was significantly lower than that in SKMM (p = 0.030), and any PMME cases showed high microsatellite instability. RNA sequencing revealed a distinctive pattern with respect to RNA expression. T cell co-stimulation differed between PMME and SKMM. These data show that the RAS-mitogen-activated protein kinase pathway is one of the main pathways involved in PMME.

5. Conclusions

PMME represents a very rare entity whose very existence has been the subject of debate for a long time. Over time, an increasing number of cases have been reported in the literature, leading to an increase in knowledge and laying the foundations for a discussion on the treatment of this pathology, which still remains largely represented by surgery. In recent times, the possibility of discovering greater mutations in gene hotspots has made it possible to develop new therapeutic strategies, of which nivolumab is an example. Future studies with large case series, with clinicopathological and molecular data, will be necessary to improve the outcome of patients with PMME.

Author Contributions

Conceptualization, G.C. (Gerardo Cazzato) and A.C.; methodology, G.C. (Gerardo Cazzato) and E.C.; software, T.L.; validation, G.C. (Gerardo Cazzato), A.C., L.R. and P.P.; formal analysis, G.C. (Gerardo Cazzato) and M.D.; investigation, F.A., V.L. and G.C. (Gennaro Cormio); resources, G.C. (Gennaro Cormio), G.I. and C.B.; data curation, G.C. (Gerardo Cazzato), L.L., S.S., N.C. and C.L.; writing—original draft preparation, G.C. (Gerardo Cazzato); writing—review and editing, G.C. (Gerardo Cazzato) and A.C.; visualization, P.P. and S.S.; supervision, A.S. and G.I. All authors have read and agreed to the published version of the manuscript.

Acknowledgments

In memory of Antonietta Cimmino.

Conflicts of Interest

The authors declare no conflict of interest.

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figure and Table

Figure 1. PRISMA 2020 flow-chart utilized in this review.

Table 1

Overall Survival and Regression-free Survival data from some studies with a great number of patients with PPME.

Author(s)	Number of Patient	Treatment	Overall Survival (OS)	Recurrence-Free Survival (RFS)	Future Prospectives
Hashimoto [306]	6	Surgery 4ICI (2)	19.6 (6.4–40.5) months	19.3 months (range, 3.9–37.9)	Additional studies
Wang [276]	76	Surgery 59Adjuvant therapy 37	22.3 months	4.5 months	PD-1 valuable option for therapy
Lasota [278]	16 (data available)	Surgery 16	4–22 months	/	New studies about NGS
Cheng [281]	9	Surgery 5PR 1Chp 1ICI 1Biotherapy 1	OS stage I: 100%OS stageOS stage III-IV:0%	/	More randomized controlled trials
Dai [285]	70	Surgery/adjuvant chemotherapy	13.5 months	/	/
Kim [302]	17	Surgery 10Chemotherapy/ICI 7	10 months	4 months	Further large-scale studies are required regarding novel treatment strategies such as immunotherapy for patients with PMME

Legend. PR: Palliative Resection; Chp: chemotherapy post-operatory; ICI: Immunocheckpoint inhibitors.

References

1. Bauer, E.H. Ein Fall von primarem Melanom des Osopagus. Arb. Geb. Pathol. Anat. Inst. Tub.; 1906; 5, pp. 343-354.

2. Limongelli, L.; Cascardi, E.; Capodiferro, S.; Favia, G.; Corsalini, M.; Tempesta, A.; Maiorano, E. Multifocal Amelanotic Melanoma of the Hard Palate: A Challenging Case. Diagnostics; 2020; 10, 424. [DOI: https://dx.doi.org/10.3390/diagnostics10060424] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32580507]

3. Ng, Y.Y.R.; Tan, G.H.C.; Quek, R.H.H.; Farid, M.B.H.R.; Soo, K.C.; Teo, M.C.C. Clinical patterns and management of primary mucosal melanoma: A single centre experience. ANZ J. Surg.; 2018; 88, pp. 1145-1150. [DOI: https://dx.doi.org/10.1111/ans.14373]

4. Blecker, D.; Abraham, S.; Furth, E.E.; Kochman, M.L. Melanoma in the gastrointestinal tract. Am. J. Gastroenterol.; 1999; 94, pp. 3427-3433. [DOI: https://dx.doi.org/10.1111/j.1572-0241.1999.01604.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10606298]

5. Puyo, R. Portmann Mélano-carcinome primitif de l’oesophage [Primary melanocarcinoma of the esophagus]. Rev. Laryngol. Oto.l Rhinol.; 1950; 71, pp. 178-183.

6. Burnett, J.M.; St. John, E. Primary melanosarcoma of the esophagus. Radiology; 1951; 57, pp. 868-870. [DOI: https://dx.doi.org/10.1148/57.6.868] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14883362]

7. Garfinkle, J.M.; Cahan, W.G. Primary melanocarcinoma of the esophagus; first histologically proved case. Cancer; 1952; 5, pp. 921-926. [DOI: https://dx.doi.org/10.1002/1097-0142(195209)5:5<921::AID-CNCR2820050508>3.0.CO;2-0]

8. Bullock, W.K.; Thompson, H.L.; Gregory, G. Primary melanocarcinoma of the esophagus; third histologically proved case. Cancer; 1953; 6, pp. 578-580. [DOI: https://dx.doi.org/10.1002/1097-0142(195305)6:3<578::AID-CNCR2820060314>3.0.CO;2-C]

9. Boyd, D.P.; Meissner, W.A.; Velkoff, C.L.; Gladding, T.C. Primary melanocarcinoma of the esophagus; report of a case. Cancer; 1954; 7, pp. 266-270. [DOI: https://dx.doi.org/10.1002/1097-0142(195403)7:2<266::AID-CNCR2820070209>3.0.CO;2-H]

10. Pomeranz, A.A.; Garlock, J.H. Primary melanocarcinoma of the esophagus. Ann. Surg.; 1955; 142, pp. 296-301. [DOI: https://dx.doi.org/10.1097/00000658-195508000-00019] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/13239067]

11. Allen, A.C.; Spitz, S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer; 1953; 6, 45. [DOI: https://dx.doi.org/10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C]

12. Keeley, J.L.; Rooney, J.A.; Guzauskas, A.C.; Brynjolfsson, G. Primary malignant melanoma of the esophagus. Surgery; 1957; 42, pp. 607-614. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/13467623]

13. Ferro, F.E.; Miller, E.W.; Morningstar, W.A.; Singerman, R.C.; Mendelsohn, H.J. Primary melanoma of the esophagus. AMA Arch. Surg.; 1958; 76, pp. 492-495. [DOI: https://dx.doi.org/10.1001/archsurg.1958.01280220010002] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/13520076]

14. Negre, E.; Guibert, H.; Cazalis, C. Naevo-épithéliomes primitifs de l’oesophage [Primary nevoepithelioma of the esophagus]. J. Chir.; 1958; 76, pp. 263-271. (In French)

15. Fleming, P.C.; Van Der Merwe, S.B. A case of primary malignant melanoma of the oesophagus. Br. J. Surg.; 1958; 46, pp. 121-123. [DOI: https://dx.doi.org/10.1002/bjs.18004619607] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/13607997]

16. Guibert, H.L.; Oriol, R. Primary melanomas of the esophagus. Rev. Laryngol. Otol. Rhinol.; 1960; 81, pp. 46-91. (In French)

17. Bartsch, W.M. Primary malignant melanoma of the esophagus. Bruns. Beitr. Klin. Chir.; 1961; 202, pp. 427-440. (In German)

18. Minwalla, S.P.; Parry, W.R. A case of primary malignant melanoma of the oesophagus. Br. J. Surg.; 1961; 48, pp. 461-462. [DOI: https://dx.doi.org/10.1002/bjs.18004821022]

19. Waken, J.K.; Bullock, W.K. Primary melanocarcinoma of the esophagus. Am. J. Clin. Pathol.; 1962; 38, pp. 415-421. [DOI: https://dx.doi.org/10.1093/ajcp/38.4.415]

20. De la Pava, S.; Nigogosyan, G.; Pickren, J.W.; Labrera, A. Melanosis of the esophagus. Cancer; 1963; 16, pp. 48-50. [DOI: https://dx.doi.org/10.1002/1097-0142(196301)16:1<48::AID-CNCR2820160107>3.0.CO;2-M]

21. Richard, C.A.; Lortat-Jacob, J.L.; Malafosse, M. Le naevo-carcinome primitif de l’oesophage [Primary nevocarcinoma of the esophagus]. Ann. Chir.; 1966; 20, pp. 971-977. (In French) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/5925427]

22. Nichet, L.; Mouchard, J. A propos d’un cas de mélanome primitif de l’oesophage [Apropos of a case of primary melanoma of the esophagus]. Ann. Otolaryngol. Chir. Cervicofac.; 1967; 84, pp. 230-231. (In French) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/6062832]

23. Witonsky, O. Primäres Melanoblastoma malignum des Osophagus [Primary malignant melanoblastoma of the esophagus]. Krebsarzte; 1968; 23, pp. 94-96. (In German)

24. Hosoda, S.; Murakami, I.; Murakami, N. Autopsy case of malignant primary melanoma of the esophagus. Gan. No. Rinsho.; 1969; 15, pp. 752-754. (In Japanese) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/5388920]

25. Piccone, V.A.; Klopstock, R.; LeVeen, H.H.; Sika, J. Primary malignant melanoma of the esophagus associated with melanosis of the entire esophagus. First case report. J. Thorac. Cardiovasc. Surg.; 1970; 59, pp. 864-870. [DOI: https://dx.doi.org/10.1016/S0022-5223(19)42411-2]

26. Coste, T.; Groussard, O.; Vallin, J.; Dupuy, R. Naevo-carcinome primitif de l’oesophage [Primary nevocarcinoma of the esophagus]. Arch. Fr. Mal. App. Dig.; 1971; 60, pp. 131-137. (In French) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/5577823]

27. Bingham, D.L.; Chadsey, L.C.; Ramchand, S.; Doris, P.J. Primary melanocarcinoma of the esophagus. Can. Med. Assoc. J.; 1971; 105, pp. 607-610. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/5118679]

28. Broderick, P.A.; Allegra, S.R.; Corvese, N. Primary malignant melanoma of the esophagus: A case report. Acta Cytol.; 1972; 16, pp. 159-164.

29. Moffat, R.C.; Richard, L.B.; Gnass, J.E. Primary malignant melanoma of the esophagus: A case report. Can. J. Surg.; 1972; 15, pp. 306-309.

30. Frable, W.J.; Kay, S.; Schatzki, P. Primary malignant melanoma of the esophagus: An electron microscopic study. Am. J. Clin. Pathol.; 1972; 58, pp. 659-667. [DOI: https://dx.doi.org/10.1093/ajcp/58.6.659]

31. Futonaka, H.; Doi, H.; Ogawa, A.; Uchiki, J.; Inoue, M. Surgery in a case of malignant primary melanoma of the esophagus. Kyobu. Geka.; 1973; 26, pp. 649-652. (In Japanese) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/4796323]

32. Turnbull, A.D.; Rosen, P.; Goodner, J.T.; Beattie, E.J. Primary malignant tumors of the esophagus other than typical epidermoid carcinoma. Ann. Thorac. Surg.; 1973; 15, pp. 463-473. [DOI: https://dx.doi.org/10.1016/S0003-4975(10)65333-7]

33. Saibil, E.; Palayew, M.J. The radiology corner. Primary malignant melanoma of the esophagus. Am. J. Gastroenterol.; 1974; 61, pp. 63-67.

34. Musher, D.R.; Lindner, A.E. Primary melanoma of the esophagus. Am. J. Dig. Dis.; 1974; 19, pp. 855-859. [DOI: https://dx.doi.org/10.1007/BF01071946] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/4853772]

35. Hendricks, G.L., Jr.; Barnes, W.T.; Suter, H.J. Primary malignant melanoma of the esophagus: A case report. Am. Surg.; 1974; 40, pp. 468-473. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/4843456]

36. Chaput, J.C.; Gourdier, S.; Martin, E.; Larrieu, H.; Etienne, J.P. Naevocarcinome primitif de l’oesophage [Primary nevocarcinoma of the esophagus]. Sem Hop.; 1974; 50, pp. 151-157. (In French)

37. Urbano, U.; Fornaciari, G. Caratteri del melanoma maligno primitivo dell’esofago con presentazione di un caso [Characteristics of primary malignant melanoma of the esophagus with report of a case]. Tumori; 1975; 61, pp. 163-172. (In Italian) [DOI: https://dx.doi.org/10.1177/030089167506100204] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1226576]

38. Mikuz, G.; Scharfetter, H.; Bernard, W.; Reisegger, W. Das primäre maligne Melanoblastom des Osophagus [Primary malignant melanoblastoma of the esophagus (author’s transl)]. Zentralbl. Allg. Pathol.; 1975; 119, pp. 189-193. (In German)

39. Holler, A.; Doyon, D.; Levasseur, P.; Blanchon, P. Mélanome malin primitif de l’oesophage [Primary malignant melanoma of the esophagus (author’s transl)]. Arch. Fr. Mal. App. Dig.; 1975; 64, pp. 249-255. (In French)

40. Kurzban, J.D.; Marshak, R.H.; Maklansky, D. Primary malignant melanoma of the esophagus. Am. J. Gastroenterol.; 1976; 65, pp. 464-465. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/949056]

41. Montgomery, A.C. Primary malignant melanoma of the oesophagus. Clin. Oncol.; 1976; 2, pp. 239-243. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1009708]

42. Månsson, T.; Berge, T. Primary malignant melanoma of the oesophagus. Acta Pathol. Microbiol. Scand. A; 1977; 85, pp. 395-398. [DOI: https://dx.doi.org/10.1111/j.1699-0463.1977.tb00440.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/878874]

43. Vaneecloo, S.; L’Hermie, M.; Houcke, M.; Quandalle, P. A propos d’un cas de naevocarcinome primitif de l’oesophage [Case of primary nevocarcinoma of the esophagus]. Lille Med.; 1977; 22, pp. 218-225. (In French) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/875600]

44. Kreuser, E.D. Primary malignant melanoma of the esophagus. Virchows Arch. A Pathol. Anat. Histol.; 1979; 385, pp. 49-59. [DOI: https://dx.doi.org/10.1007/BF00433540] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/162100]

45. Assor, D.; Santa Cruz, D. Multifocal malignant melanoma of the esophagus. South. Med. J.; 1979; 72, pp. 1009-1012. [DOI: https://dx.doi.org/10.1097/00007611-197908000-00034] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/472796]

46. Liu, F.S.; Zhang, D.W. Primary malignant melanoma of the esophagus. Zhonghua Zhong Liu Za Zhi; 1979; 1, pp. 71-74. (In Chinese) [DOI: https://dx.doi.org/10.1007/s10330-007-0142-0] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/552361]

47. Jawalekar, K.; Tretter, P. Primary malignant melanoma of the esophagus: Report of two cases. J. Surg. Oncol.; 1979; 12, pp. 19-25. [DOI: https://dx.doi.org/10.1002/jso.2930120104]

48. McCormack, P.M.; Nascimento, A.G.; Bains, M.S.; Knapper, W.H.; Zaman, M.B. Primary melanocarcinoma of the esophagus. Clin. Bull.; 1979; 9, pp. 162-164. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/540421]

49. Farsad, G.R. Primary malignant melanoma of the esophagus. South. Med. J.; 1980; 73, pp. 1535-1537. [DOI: https://dx.doi.org/10.1097/00007611-198011000-00036]

50. Sostman, H.D.; Keohane, M.F.; Lee, C.H.; Curtis, A.M.; Farman, J. Primary oesophageal melanocarcinoma. Br. J. Radiol.; 1980; 53, pp. 589-592. [DOI: https://dx.doi.org/10.1259/0007-1285-53-630-589]

51. Ludwig, M.E.; Shaw, R.; de Suto-Nagy, G. Primary malignant melanoma of the esophagus. Cancer; 1981; 48, pp. 2528-2534. [DOI: https://dx.doi.org/10.1002/1097-0142(19811201)48:11<2518::AID-CNCR2820481131>3.0.CO;2-R]

52. Estrera, A.S.; Graham, H.M.; Platt, M.R.; Schorn, L.W.; Mack, M. Primary malignant melanoma of the esophagus: A case report. Tex. Med.; 1981; 77, pp. 64-66. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/6965165]

53. Benasco, C.; Margarit, C.L.; Combalia, N.; Curto Cardus, J. Melanoma primario de esófago. Aportación de un caso y revisión de la literatura [Primary melanoma of the esophagus. Report of a case and review of the literature]. Rev. Esp. Enferm. Apar. Dig.; 1982; 62, pp. 401-407. (In Spanish) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7167673]

54. Go, A.T.; Zirkin, R.M. Primary malignant melanoma of the esophagus: A case report with endoscopic and electron microscopic studies. Am. J. Gastroenterol.; 1982; 77, pp. 840-843. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7137136]

55. Takubo, K.; Kanda, Y.; Ishii, M.; Nonose, N.; Saida, T.; Fujita, K.; Nakagawa, H.; Fujiwara, M. Primary malignant melanoma of the esophagus. Hum. Pathol.; 1983; 14, pp. 727-730. [DOI: https://dx.doi.org/10.1016/S0046-8177(83)80147-6]

56. Aldovini, D.; Detassis, C.; Piscioli, F. Primary malignant melanoma of the esophagus. Brush cytology and histogenesis. Acta Cytol.; 1983; 27, pp. 65-68.

57. Alberti, J.E.; Bodor, J.; Torres, A.D.; Pini, N. Melanoma maligno primitivo del esófago asociado a melanosis del esófago y del estómago [Primary malignant melanoma of the esophagus associated with melanosis of the esophagus and stomach]. Acta Gastroenterol. Latinoam.; 1984; 14, pp. 139-148. (In Spanish)

58. Ghussen, F.; Günther, M.; Nagel, K.; Rohner, H.G. Primäres malignes Melanom des Osophagus [Primary malignant melanoma of the esophagus]. Leber Magen. Darm.; 1984; 14, pp. 28-30. (In German)

59. Okazaki, A.; Itoh, J.; Tatezawa, T.; Yamanaka, M.; Matsuura, M.; Aiba, S.; Nishimura, T.; Niibe, H. [An autopsy case of primary malignant melanoma of the esophagus—Appraisal of radiation therapy]. Gan No Rinsho; 1984; 30, pp. 943-949. (In Japanese)

60. Kyösola, K.; Harjula, A.; Heikkinen, L.; Timonen, T.; Miettinen, M. Primary malignant melanoma of the oesophagus. A case report. Scand. J. Thorac. Cardiovasc. Surg.; 1984; 18, pp. 267-270. [DOI: https://dx.doi.org/10.3109/14017438409109906]

61. Roesch, W.; Rohner, H.G. Primary malignant melanoma of the oesophagus. Endoscopy; 1984; 16, pp. 186-188. [DOI: https://dx.doi.org/10.1055/s-2007-1018578] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/6489277]

62. Domeki, K.; Noto, N.; Kikuchi, Y.; Kitajima, S.; Jin, M.; Kaimori, M.; Takaya, H. Primary malignant melanoma of the esophagus. Nihon Kyobu Geka Gakkai Zasshi; 1984; 32, pp. 110-114. (In Japanese) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/6726018]

63. Chalkiadakis, G.; Wihlm, J.M.; Morand, G.; Weill-Bousson, M.; Witz, J.P. Primary malignant melanoma of the esophagus. Ann. Thorac. Surg.; 1985; 39, pp. 472-475. [DOI: https://dx.doi.org/10.1016/S0003-4975(10)61963-7]

64. Boulafendis, D.; Damiani, M.; Sie, E.; Bastounis, E.; Samaan, H.A. Primary malignant melanoma of the esophagus in a young adult. Am. J. Gastroenterol.; 1985; 80, pp. 417-420. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/4003370]

65. Kato, N.; Kamino, K.; Yamashita, T.; Umeyama, K.; Mitsuhashi, T. Primary malignant melanoma of the esophagus. Gan. No Rinsho.; 1986; 32, pp. 1459-1465. (In Japanese) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3773274]

66. Lautz, H.U.; Schmidt, F.W.; Cullen, P. Primary malignant melanoma of the esophagus. Endoscopy; 1986; 18, pp. 240-242. [DOI: https://dx.doi.org/10.1055/s-2007-1018389]

67. Li, Z.J.; Zhu, Z.X.; Liu, H.R.; Wang, G.M.; Xu, L.T. Primary malignant melanoma of the esophagus (report of two cases). Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll.; 1986; 1, pp. 180-184.

68. DiCostanzo, D.P.; Urmacher, C. Primary malignant melanoma of the esophagus. Am. J. Surg. Pathol.; 1987; 11, pp. 46-52. [DOI: https://dx.doi.org/10.1097/00000478-198701000-00006]

69. Morrison, J.G.; Halter, S.A.; Merrill, W.H. Malignant melanoma of the esophagus. South. Med. J.; 1987; 80, pp. 1184-1187. [DOI: https://dx.doi.org/10.1097/00007611-198708090-00027]

70. Milman, P.J. Primary malignant melanoma of the esophagus. Gastrointest. Endosc.; 1987; 33, pp. 36-37. [DOI: https://dx.doi.org/10.1016/S0016-5107(87)71485-0]

71. Woodtli, W.; Widmer, A.; Matter, H.; Burger, H.R. Primäres malignes Melanom des Osophagus [Primary malignant melanoma of the esophagus]. Schweiz Rundsch. Med. Prax.; 1987; 76, pp. 28-30. (In German) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3823685]

72. Arrighi, D.A.; Pemberton, L.B.; Niederee, W.C. Primary melanoma of the esophagus: A case report. Mo. Med.; 1987; 84, pp. 296-298. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3509132]

73. Jensen, D.; Stark, P.; Gardiner, G.; Hyde, M. Primary malignant melanoma of the esophagus. Rofo; 1988; 149, pp. 330-331. [DOI: https://dx.doi.org/10.1055/s-2008-1048354]

74. Isaacs, J.L.; Quirke, P. Two cases of primary malignant melanoma of the oesophagus. Clin. Radiol.; 1988; 39, pp. 455-457. [DOI: https://dx.doi.org/10.1016/S0009-9260(88)80309-X]

75. Schmutz, G.; Drape, J.L.; Weill-Bousson, M.; Wihlm, J.M.; Adloff, M.; Bockel, R. Les mélanomes malins primitifs du tractus digestif: Oesophage et rectum. A propos de 2 observations [Primary malignant melanoma of the digestive tract: Esophagus and rectum. Apropos of 2 cases]. J. Radiol.; 1988; 69, pp. 285-289. (In French) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3385687]

76. Martínez Araque, M.J.; Moya Herráiz, A.; Chirivella Casanova, M.; López Aldeguer, J. Melanoma primario del esófago, asociado a melanosis. Aportación de un caso [Primary melanoma of the esophagus, associated with melanosis. Report of a case]. Rev. Esp. Enferm. Apar. Dig.; 1988; 74, pp. 67-69. (In Spanish) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3175245]

77. Sabanathan, S.; Eng, J.; Pradhan, G.N. Primary malignant melanoma of the esophagus. Am. J. Gastroenterol.; 1989; 84, pp. 1475-1481. [DOI: https://dx.doi.org/10.3109/14017439009101830]

78. Guzman, R.P.; Wightman, R.; Ravinsky, E.; Unruh, H.W. Primary malignant melanoma of the esophagus with diffuse melanocytic atypia and melanoma in situ. Am. J. Clin. Pathol.; 1989; 92, pp. 802-804. [DOI: https://dx.doi.org/10.1093/ajcp/92.6.802]

79. Kanavaros, P.; Galian, A.; Périac, P.; Dyan, S.; Licht, H.; Lavergne, A. Mélanome malin primitif de l’oesophage développé sur une mélanose. Etude histologique, immunohistochimique et ultrastructurale d’un cas [Primary malignant melanoma of the esophagus arising in melanosis. Histological, immunohistochemical and ultrastructural study of a case]. Ann. Pathol.; 1989; 9, pp. 57-61. (In French)

80. Yamashita, Y.; Hirai, T.; Mukaida, H.; Kawano, K.; Toge, T.; Niimoto, M.; Hattori, T.; Kunita, T. Primary malignant melanoma of the esophagus—A case report. Jpn. J. Surg.; 1989; 19, pp. 498-501. [DOI: https://dx.doi.org/10.1007/BF02471636]

81. Bĕhal, L. Melanoblastom jícnu [Melanoblastoma of the esophagus]. Cesk. Radiol.; 1989; 43, pp. 237-240. (In Czech)

82. Moncada, K.; Bremondy, A.; Grimaud, J.C.; Thervet, L.; Sahel, J.; Lebreuil, G.; Salducci, J. Primary malignant melanoma of the esophagus. Surg. Endosc.; 1990; 4, pp. 122-123. [DOI: https://dx.doi.org/10.1007/BF00591275] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2197749]

83. Taniyama, K.; Suzuki, H.; Sakuramachi, S.; Toyoda, T.; Matsuda, M.; Tahara, E. Amelanotic malignant melanoma of the esophagus: Case report and review of the literature. Jpn. J. Clin. Oncol.; 1990; 20, pp. 286-295. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2255105]

84. Aagaard, M.T.; Kristensen, I.B.; Lund, O.; Hasenkam, J.M.; Kimose, H.H. Primary malignant non-epithelial tumours of the thoracic oesophagus and cardia in a 25-year surgical material. Scand. J. Gastroenterol.; 1990; 25, pp. 876-882. [DOI: https://dx.doi.org/10.3109/00365529008997607]

85. Bo, S.; Eng, J. Primary malignant melanoma of the esophagus. Scand. J. Thorac. Cardiovasc. Surg.; 1990; 24, pp. 83-85. [DOI: https://dx.doi.org/10.3109/14017439009101830]

86. Lucev, M.; Turi, V.; D’Abrosca, F.; Gerosa, E.; Villani, L. Il melanoma primitivo dell’esofago [Primary melanoma of the esophagus]. Minerva Chir.; 1990; 45, pp. 195-197. (In Italian)

87. Ruiz-Cabello, J.M.; Pérez de las Vacas, B.J.; Rosado, G.M.; González, N.M. Melanoma maligno primario de esófago [Primary malignant melanoma of the esophagus]. Rev. Esp. Enferm. Dig.; 1990; 78, pp. 93-95. (In Spanish) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2271301]

88. Krause, U.; Donhuijsen, K.; Schax, M.; Niebel, W. Das primäre maligne Melanom der Speiseröhre [Primary malignant melanoma of the esophagus]. Chirurgia; 1990; 61, pp. 32-35. (In German)

89. Woolery, W.A.; Tripodis, S.P.; Chacko, D.C. Endoscopic Nd:YAG laser and radiation therapy for primary malignant melanoma of the esophagus. J. Am. Osteopath. Assoc.; 1990; 90, pp. 543-546.

90. Shinoda, M.; Takagi, I.; Yoshii, Y.; Suzuki, R. Primary malignant melanoma of the esophagus. Gastrointest. Endosc.; 1990; 36, pp. 321-322. [DOI: https://dx.doi.org/10.1016/S0016-5107(90)71046-2]

91. Simpson, N.S.; Spence, R.A.; Biggart, J.D.; Cameron, C.H. Primary malignant melanoma of the oesophagus. J. Clin. Pathol.; 1990; 43, pp. 82-83. [DOI: https://dx.doi.org/10.1136/jcp.43.1.82-b] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2312756]

92. Kato, H.; Watanabe, H.; Tachimori, Y.; Watanabe, H.; Iizuka, T.; Yamaguchi, H.; Ishikawa, T.; Itabashi, M. Primary malignant melanoma of the esophagus: Report of four cases. Jpn. J. Clin. Oncol.; 1991; 21, pp. 306-313. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1942560]

93. Caldwell, C.B.; Bains, M.S.; Burt, M. Unusual malignant neoplasms of the esophagus. Oat cell carcinoma, melanoma, and sarcoma. J. Thorac. Cardiovasc. Surg.; 1991; 101, pp. 100-107. [DOI: https://dx.doi.org/10.1016/S0022-5223(19)36798-4]

94. Stranks, G.J.; Mathai, J.T.; Rowe-Jones, D.C. Primary malignant melanoma of the oesophagus: Case report and review of surgical pathology. Gut; 1991; 32, pp. 828-830. [DOI: https://dx.doi.org/10.1136/gut.32.7.828] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1855693]

95. Hamdy, F.C.; Smith, J.H.; Kennedy, A.; Thorpe, J.A. Long survival after excision of a primary malignant melanoma of the oesophagus. Thorax; 1991; 46, pp. 397-398. [DOI: https://dx.doi.org/10.1136/thx.46.5.397] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2068703]

96. Mannell, A.; Hunter, S.J.; Hale, M.J. Primary malignant melanoma of the oesophagus. Report of a case with flow cytometric DNA analysis. S. Afr. J. Surg.; 1991; 29, pp. 120-122.

97. Prabhu, S.R.; Puranik, G.V.; Menezes, W. Primary malignant melanoma of esophagus. Indian J. Gastroenterol.; 1991; 10, pp. 109-110.

98. De Mik, J.I.; Kooijman, C.D.; Hoekstra, J.B.; Tytgat, G.N. Primary malignant melanoma of the oesophagus. Histopathology; 1992; 20, pp. 77-79. [DOI: https://dx.doi.org/10.1111/j.1365-2559.1992.tb00923.x]

99. Pavanello, M.; Bardini, R.; Asolati, M.; Castoro, C.; Anselmino, M.; Peracchia, A. Il melanoma maligno primitivo dell’esofago. Considerazioni su 3 casi osservati e revisione della letteratura [Primary malignant melanoma of the esophagus. Report of 3 cases and review of the literature]. Minerva Chir.; 1993; 48, pp. 157-161. (In Italian) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8479652]

100. Haga, Y.; Iwanaga, Y.; Matsumura, F.; Nakamura, T.; Ohtsu, S.; Yagi, Y.; Nakamura, Y.; Tanimura, M. Curatively resected primary malignant melanoma of the esophagus: Report of a case. Surg. Today; 1993; 23, pp. 820-824. [DOI: https://dx.doi.org/10.1007/BF00311627]

101. Chello, M.; Marchese, A.R.; Panza, A.; Mastroroberto, P.; Di Lello, F. Primary malignant melanoma of the oesophagus with a left atrial metastasis. Thorax; 1993; 48, pp. 185-186. [DOI: https://dx.doi.org/10.1136/thx.48.2.185] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8493638]

102. Kunkel, D.; Carloz, E.; Prignet, J.M.; Houdelette, P.; Jaubert, D.; De Jaureguiberry, J.P.; Gagliano-Giunta, M.G. Mélanome primitif de l’oesophage [Primary melanoma of the esophagus]. Gastroenterol. Clin. Biol.; 1993; 17, pp. 963-967. (In French) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8125231]

103. Mohandas, K.M.; Santhi Swaroop, V.; Dhir, V.; Vyas, J.J. Primary malignant melanoma of the esophagus palliated with endoscopic laser therapy. Endoscopy; 1993; 25, 551. [DOI: https://dx.doi.org/10.1055/s-2007-1010401]

104. Seyama, A.; Morikage, N.; Takahashi, T.; Esato, K.; Fujita, Y. A case of multiple primary malignant melanoma of the esophagus. Nihon Kyobu Gek. Gakkai Zasshi; 1994; 42, pp. 110-115. (In Japanese)

105. Al-Karawi, M.A.; Mohamed, S.A.; Macdougall, C. Primary malignant melanoma of esophagus. Ann. Saudi Med.; 1994; 14, pp. 348-350. [DOI: https://dx.doi.org/10.5144/0256-4947.1994.348]

106. Loftus, B.M.; Broe, P.; Johnston, O.; Leader, M. Primary amelanotic malignant melanoma of the oesophagus—A case report. Ir. J. Med. Sci.; 1994; 163, pp. 128-131. [DOI: https://dx.doi.org/10.1007/BF02965971]

107. Joob, A.W.; Haines, G.K.; Kies, M.S.; Shields, T.W. Primary malignant melanoma of the esophagus. Ann. Thorac. Surg.; 1995; 60, pp. 217-222. [DOI: https://dx.doi.org/10.1016/S0003-4975(95)00084-4]

108. Yoshikane, H.; Suzuki, T.; Yoshioka, N.; Ogawa, Y.; Hamajima, E.; Hasegawa, N.; Nakamura, S.; Kamiya, Y. Primary malignant melanoma of the esophagus presenting with massive hematemesis. Endoscopy; 1995; 27, pp. 397-399. [DOI: https://dx.doi.org/10.1055/s-2007-1005721]

109. Deligeorgi-Politi, H.; Kairi-Vassilatou, E. Primary malignant melanoma of the esophagus. Ann. Saudi Med.; 1995; 15, pp. 293-294. [DOI: https://dx.doi.org/10.5144/0256-4947.1995.293b]

110. Chan, H.S.; Nambiar, R. Malignant melanoma of the oesophagus—A case report. Singap. Med. J.; 1995; 36, pp. 566-567.

111. Ribeiro, U., Jr.; Safatle-Ribeiro, A.V.; Clarke, M.R.; Posner, M.C. Primary malignant melanoma of the esophagus. Am. J. Gastroenterol.; 1996; 91, pp. 1048-1049.

112. Cosme, A.; Bujanda, L.; Torrado, J.; Berdejo, L.; Ojeda, E.; Castiella, A.; Montalvo, I.; Gil, I. Melanoma primario de esófago. Dos nuevos casos [Primary melanoma of the esophagus. 2 new cases]. Rev. Esp. Enferm. Dig.; 1996; 88, pp. 705-708. (In Spanish)

113. Craig, S.R.; Wallace, W.H.; Ramesar, K.C.; Cameron, E.W. Primary malignant melanoma of the esophagus. Hepatogastroenterology; 1996; 43, pp. 519-520.

114. Germer, C.T.; Albrecht, D.; Foss, H.D.; Buhr, H.J. Primary malignant melanoma of the oesophagus. Eur. J. Surg. Oncol.; 1996; 22, pp. 118-120. [DOI: https://dx.doi.org/10.1016/S0748-7983(96)91979-4]

115. Namieno, T.; Koito, K.; Ambo, T.; Muraoka, S.; Uchino, J. Primary malignant melanoma of the esophagus: Diagnostic value of endoscopic ultrasonography. Am. Surg.; 1996; 62, pp. 716-718.

116. Uthoff, K.; Jähne, J.; Meyer, H.J.; Pichlmayr, R. Chirurgische Therapie des primären malignen Melanoms des Oesophagus [Surgical therapy of primary malignant melanoma of the esophagus]. Chirurgia; 1996; 67, pp. 86-89. (In German)

117. Oviedo de Albiero, M.M.; de Fabro, S.P. Melanoma maligno primario de esófago: Presentación de un caso [Primary malignant esophageal melanoma: Report of a case]. Rev. Fac. Cien. Med. Univ. Nac. Cordoba.; 1996; 54, pp. 27-30. (In Spanish)

118. Takahashi, T.; Iwata, Y.; Imaeda, H.; Watanabe, T.; Miyazawa, M.; Takeuchi, I.; Kameya, K.; Ariwa, R. Case of primary esophageal melanoma discovered as sub-mucosal tumor of the esophagus. Nihon Naika Gakkai Zasshi.; 1996; 85, pp. 1147-1149. (In Japanese)

119. DeMatos, P.; Wolfe, W.G.; Shea, C.R.; Prieto, V.G.; Seigler, H.F. Primary malignant melanoma of the esophagus. J. Surg. Oncol.; 1997; 66, pp. 201-206. [DOI: https://dx.doi.org/10.1002/(SICI)1096-9098(199711)66:3<201::AID-JSO9>3.0.CO;2-G]

120. Niezychowska, K.; Zawádzki, J.; Wejman, J. Primary malignant melanoma of the esophagus. A case report. Pol. J. Pathol.; 1997; 48, pp. 205-207.

121. Adili, F.; Mönig, S.P. Surgical therapy of primary malignant melanoma of the esophagus. Ann. Thorac. Surg.; 1997; 63, pp. 1461-1463. [DOI: https://dx.doi.org/10.1016/S0003-4975(97)00111-2]

122. Ishigooka, M.; Yamasaki, S.; Hirao, M.; Takanashi, S.; Iida, J.; Kashiyama, M.; Matuge, S.; Hara, T.; Kawashima, H.; Hatakeyama, H. et al. A case of primary malignant melanoma of the esophagus. Kyobu Geka; 1997; 50, pp. 413-416. (In Japanese)

123. Kanamoto, K.; Aoyagi, K.; Nakamura, S.; Kobayashi, H.; Fujishima, M. The value of endoscopic ultrasonography in primary malignant melanoma of the esophagus. Gastrointest. Endosc.; 1997; 46, pp. 88-89. [DOI: https://dx.doi.org/10.1016/s0016-5107(97)70221-9]

124. Muto, M.; Saito, Y.; Koike, T.; Yamagiwa, Y.; Iijima, K.; Ikeya, S.; Sasaki, T.; Nakayama, H.; Hoshino, E.; Sugai, Y. et al. Primary malignant melanoma of the esophagus with diffuse pigmentation resembling superficial spreading melanoma. Am. J. Gastroenterol.; 1997; 92, pp. 1936-1937.

125. Yoo, C.C.; Levine, M.S.; McLarney, J.K.; Lowry, M.A. Primary malignant melanoma of the esophagus: Radiographic findings in seven patients. Radiology; 1998; 209, pp. 455-459. [DOI: https://dx.doi.org/10.1148/radiology.209.2.9807573]

126. Naomoto, Y.; Perdomo, J.A.; Kamikawa, Y.; Haisa, M.; Yamatsuji, T.; Kenzo, A.; Taguchi, K.; Hara, K.; Tanaka, N. Primary malignant melanoma of the esophagus: Report of a case successfully treated with pre- and post-operative adjuvant hormone-chemotherapy. Jpn. J. Clin. Oncol.; 1998; 28, pp. 758-761. [DOI: https://dx.doi.org/10.1093/jjco/28.12.758]

127. Lee, S.H.; Park, S.H.; Kim, H.G.; Kim, C.B. Primary malignant melanoma of the esophagus. Yonsei Med. J.; 1998; 39, pp. 468-473. [DOI: https://dx.doi.org/10.3349/ymj.1998.39.5.468]

128. Yano, M.; Shiozaki, H.; Murata, A.; Inoue, M.; Tamura, S.; Taniguchi, M.; Monden, M. Primary malignant melanoma of the esophagus associated with adenocarcinoma of the lung. Surg. Today; 1998; 28, pp. 405-408. [DOI: https://dx.doi.org/10.1007/s005950050150]

129. Friedrich, T.; Emmrich, P. Das primäre maligne Melanom des Osophagus [Primary malignant melanoma of the esophagus]. Zentralbl. Chir.; 1998; 123, pp. 276-279. (In German)

130. Simonov, N.N.; Turkevich, E.A.; Gel’fond, V.M.; Lisitsyna, L.K.; Aristidov, N.I.; Gorokhov, L.V.; Puminova, O.I. Pervichnaia zlokachestvennaia melanoma vnutrigrudnogo otdela pishchevoda [Primary malignant melanoma of the intrathoracic part of the esophagus]. Vestn. Khir. Im. II Grek.; 1998; 157, pp. 71-73. (In Russian)

131. Benito Sánchez, F.G.; Jiménez Pérez, C.; González Arias, R.; Sáez García, M.A.; García Benavente, A.; Montero Vázquez, J.M. Melanoma esofágico primario [Primary esophageal melanoma]. Gastroenterol. Hepatol.; 1998; 21, pp. 283-286. (In Spanish) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9711011]

132. Mukaiya, M.; Hirata, K.; Tarumi, K.; Takashima, T.; Hata, F.; Denno, R.; Koito, K.; Takahashi, S.; Satoh, M. Surgical treatment for recurrent tumors of primary malignant melanoma of the esophagus: A case report and review of the literature. Hepatogastroenterology; 1999; 46, pp. 295-298. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10228810]

133. Gollub, M.J.; Prowda, J.C. Primary melanoma of the esophagus: Radiologic and clinical findings in six patients. Radiology; 1999; 213, pp. 97-100. [DOI: https://dx.doi.org/10.1148/radiology.213.1.r99oc3797] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10540647]

134. Syrigos, K.N.; Konstadoulakis, M.M.; Ricaniades, N.; Leandros, M.; Karakousis, C.P. Primary malignant melanoma of the esophagus: Report of two cases and review of the literature. In Vivo; 1999; 13, pp. 421-422.

135. Lam, K.Y.; Law, S.; Wong, J. Malignant melanoma of the oesophagus: Clinicopathological features, lack of p53 expression and steroid receptors and a review of the literature. Eur. J. Surg. Oncol.; 1999; 25, pp. 168-172. [DOI: https://dx.doi.org/10.1053/ejso.1998.0621]

136. Archer, H.A.; Owen, W.J. Primary malignant melanoma of the esophagus. Dis. Esophagus; 2000; 13, pp. 320-323. [DOI: https://dx.doi.org/10.1046/j.1442-2050.2000.00140.x]

137. De Perrot, M.; Bründler, M.A.; Robert, J.; Spiliopoulos, A. Primary malignant melanoma of the esophagus. Dis. Esophagus; 2000; 13, pp. 172-174. [DOI: https://dx.doi.org/10.1046/j.1442-2050.2000.00108.x]

138. Gadour, M.O.; Ayoola, E.A. Primary malignant melanoma of the oesophagus: Case report and review. Trop. Gastroenterol.; 2000; 21, pp. 185-187. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11194582]

139. Guermazi, A.; Rili, M.; Fritsch, S.; Turki, C.; Benchaïb, N.; de Kerviler, E.; Frija, J.; Sarfati, E. Mélanome malin primitif de l’oesophage [Primary malignant melanoma of the esophagus]. Ann. Chir.; 2000; 125, pp. 985-988. (In French) [DOI: https://dx.doi.org/10.1016/S0003-3944(00)00404-1]

140. Kido, T.; Morishima, H.; Nakahara, M.; Nakao, K.; Tanimura, H.; Nishimura, R.; Tsujimoto, M. Early stage primary malignant melanoma of the esophagus. Gastrointest. Endosc.; 2000; 51, pp. 90-91. [DOI: https://dx.doi.org/10.1016/S0016-5107(00)70397-X]

141. Sagie, B.; Kashtan, H.; Kluger, Y. Primary malignant melanoma of the esophagus. Isr. Med. Assoc. J.; 2000; 2, pp. 557-558. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10979338]

142. Boni, L.; Benevento, A.; Dionigi, G.; Dionigi, R. Primary malignant melanoma of the esophagus: A case report. Surg. Endosc.; 2002; 16, pp. 359-360. [DOI: https://dx.doi.org/10.1007/s00464-001-4223-9]

143. Cuesta-Mejías, T.; de León-Bojorge, B.; Arias-Gutiérrez, A.; Decanini-Terán, C.; Shueke-Esses, M. Melanoma primario en el esófago. Caso inusual con esófago de Barrett [Primary melanoma of the esophagus. Unusual case with Barrett’s esophagus]. Rev. Gastroenterol. Mex.; 2001; 66, pp. 146-149. (In Spanish) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11917448]

144. Khoury-Helou, A.; Lozac’h, C.; Vandenbrouke, F.; Lozac’h, P. Le mélanome malin primitif de l’oesophage [Primary malignant melanoma of the esophagus]. Ann. Chir.; 2001; 126, pp. 557-560. (In French) [DOI: https://dx.doi.org/10.1016/S0003-3944(01)00553-3]

145. Kastl, S.; Wutke, R.; Czeczatka, P.; Hohenberger, W.; Horbach, T. Palliation of a primary malignant melanoma of the distal esophagus by stent implantation. Report of a case. Surg. Endosc.; 2001; 15, pp. 1042-1043. [DOI: https://dx.doi.org/10.1007/s004640042030]

146. Matsutani, T.; Onda, M.; Miyashita, M.; Hagiwara, N.; Akiya, Y.; Takubo, K.; Yamashita, K.; Sasajima, K. Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy. Dis. Esophagus.; 2001; 14, pp. 241-244. [DOI: https://dx.doi.org/10.1046/j.1442-2050.2001.00193.x]

147. Herman, J.; Duda, M.; Lovecek, M.; Svach, I. Primary malignant melanoma of the esophagus treated by endoscopic ablation and interferon therapy. Dis. Esophagus.; 2001; 14, pp. 239-240. [DOI: https://dx.doi.org/10.1046/j.1442-2050.2001.00192.x]

148. Alves, A.; Maillochaud, J.H.; Sauvanet, A.; O’Toole, D.; Couvelard, A.; Ruszniewski, P.; Belghiti, J. Mélanome malin primitif de l’oesophage: Intérêt de l’échoendoscopie dans le bilan d’extension [Primary malignant melanoma of the esophagus: Value of endoscopic ultrasonography in the assessment of extension]. Gastroenterol. Clin. Biol.; 2001; 25, pp. 1117-1118. (In French)

149. Mikami, T.; Fukuda, S.; Shimoyama, T.; Yamagata, R.; Nishiya, D.; Sasaki, Y.; Uno, Y.; Saito, H.; Takaya, S.; Kamata, Y. et al. A case of early-stage primary malignant melanoma of the esophagus. Gastrointest. Endosc.; 2001; 53, pp. 365-367. [DOI: https://dx.doi.org/10.1016/S0016-5107(01)70420-8]

150. Xinopoulos, D.; Archavlis, E.M.; Kontou, M.; Tsamakidis, K.; Dimitroulopoulos, D.; Soutos, D.; Paraskevas, E.M. Primary melanoma of the oesophagus treated endoscopically. A case report. Dig. Liver Dis.; 2001; 33, pp. 254-257. [DOI: https://dx.doi.org/10.1016/S1590-8658(01)80716-7]

151. Volpin, E.; Sauvanet, A.; Couvelard, A.; Belghiti, J. Primary malignant melanoma of the esophagus: A case report and review of the literature. Dis. Esophagus.; 2002; 15, pp. 244-249. [DOI: https://dx.doi.org/10.1046/j.1442-2050.2002.00237.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12444999]

152. Boni, L.; Benevento, A.; Cabrini, L.; Dionigi, G.; Dionigi, R. Primary melanoma of the esophagus. J. Am. Coll. Surg.; 2002; 194, 840. [DOI: https://dx.doi.org/10.1016/S1072-7515(02)01168-7]

153. Brown, R.M.; Darnton, S.J.; Papadaki, L.; Antonakopoulos, G.N.; Newman, J. A primary tumour of the oesophagus with both melanocytic and schwannian differentiation. Melanocytic schwannoma or malignant melanoma?. J. Clin. Pathol.; 2002; 55, pp. 318-320. [DOI: https://dx.doi.org/10.1136/jcp.55.4.318] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11919222]

154. Holck, S.; Siemsen, M.; Jensen, D.B.; Mogensen, A.M. Endoscopic ultrasonography-guided fine needle aspiration biopsy for staging malignant melanoma of the esophagus. A case report. Acta Cytol.; 2002; 46, pp. 744-748. [DOI: https://dx.doi.org/10.1159/000326989]

155. Lin, C.Y.; Cheng, Y.L.; Huang, W.H.; Lee, S.C. Primary malignant melanoma of the oesophagus presenting with massive melena and hypovolemic shock. ANZ J. Surg.; 2002; 72, pp. 62-64. [DOI: https://dx.doi.org/10.1046/j.1445-2197.2002.02297.x]

156. Benferhat, S.; Lessourd, A.; Lévy, P.; Feydy, P.; Has, H.; Carton, S. Mélanome primitif de l’oesophage [Primary malignant melanoma of the esophagus]. Gastroenterol. Clin. Biol.; 2003; 27, pp. 113-115. (In French)

157. Lohmann, C.M.; Hwu, W.J.; Iversen, K.; Jungbluth, A.A.; Busam, K.J. Primary malignant melanoma of the oesophagus: A clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens. Melanoma Res.; 2003; 13, pp. 595-601. [DOI: https://dx.doi.org/10.1097/00008390-200312000-00009]

158. Coté, T.R.; Sobin, L.H. Primary melanomas of the esophagus and anorectum: Epidemiologic comparison with melanoma of the skin. Melanoma Res.; 2009; 19, pp. 58-60. [DOI: https://dx.doi.org/10.1097/CMR.0b013e32831ef262]

159. Tachimori, Y. The Registration Committee for Esophageal Cancer of the Japan Esophageal Society Ozawa, S.; Numasaki, H.; Ishihara, R.; Matsubara, H.; Muro, K.; Oyama, T.; Toh, Y.; Udagawa, H. et al. Comprehensive registry of esophageal cancer in Japan, 2012. Esophagus; 2019; 16, pp. 221-245. [DOI: https://dx.doi.org/10.1007/s10388-019-00674-z]

160. Gul, Y.A.; Prasannan, S.; Hairuszah, I. Primary malignant melanoma of the oesophagus. Acta Chir. Belg.; 2003; 103, pp. 420-422. [DOI: https://dx.doi.org/10.1080/00015458.2003.11679458]

161. Gao, Y.; Zhu, J.; Lin, W.; Zheng, W. Primary malignant melanoma of esophagogastric junction: A case report. Chin. Med. J.; 2003; 116, pp. 1435-1437. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14562785]

162. Yamaguchi, T.; Shioaki, Y.; Koide, K.; Kurioka, H.; Nobutani, K.; Funatsu, E.; Kutsumi, H.; Fujimoto, S.; Hosokawa, Y. A case of primary malignant melanoma of the esophagus and analysis of 193 patients in Japan. Nihon Shokakibyo Gakkai Zasshi; 2004; 101, pp. 1087-1094. (In Japanese) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15529781]

163. Uetsuka, H.; Naomoto, Y.; Fujiwara, T.; Shirakawa, Y.; Noguchi, H.; Yamatsuji, T.; Haisa, M.; Matsuoka, J.; Gunduz, M.; Takubo, K. et al. Primary malignant melanoma of the esophagus: Long-term survival following pre- and postoperative adjuvant hormone/chemotherapy. Dig. Dis. Sci.; 2004; 49, pp. 1646-1651. [DOI: https://dx.doi.org/10.1023/B:DDAS.0000043379.60295.cb] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15573920]

164. Dabrowski, A.; Skoczylas, T.; Misztal, B.; Wallner, G. Trudności diagnostyczno-terapeutyczne u chorej na pierwotnego czerniaka przełyku—Opisu przypadku [Diagnostic and therapeutic difficulties in a patient with primary malignant melanoma of the esophagus—Case report]. Pol. Merkur. Lekarski.; 2004; 17, pp. 378-379. (In Polish)

165. Patonay, P.; Naszály, A.; Mayer, A.; Pócza, K.; Kovács, L. Irreszekábilis elsôdleges nyelôcsô melanoma malignum radiokemoterápiája [Radio-chemotherapy for non-resectable primary esophageal malignant melanoma]. Magy. Onkol.; 2004; 48, pp. 303-308. (In Hungarian)

166. Fogarty, G.B.; Tartaglia, C.J.; Peters, L.J. Primary melanoma of the oesophagus well palliated by radiotherapy. Br. J. Radiol.; 2004; 77, pp. 1050-1052. [DOI: https://dx.doi.org/10.1259/bjr/26921127] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15569650]

167. Wayman, J.; Irving, M.; Russell, N.; Nicoll, J.; Raimes, S.A. Intraluminal radiotherapy and Nd:YAG laser photoablation for primary malignant melanoma of the esophagus. Gastrointest. Endosc.; 2004; 59, pp. 927-929. [DOI: https://dx.doi.org/10.1016/S0016-5107(04)00339-6]

168. Awsare, M.; Friedberg, J.S.; Coben, R. Primary malignant melanoma of the esophagus. Clin. Gastroenterol. Hepatol.; 2005; 3, xxvii. [DOI: https://dx.doi.org/10.1016/S1542-3565(05)00362-9]

169. Asakage, M.; Kitayama, J.; Tsuno, N.H.; Komuro, Y.; Kaisaki, S.; Hori, N.; Nagawa, H.; Tsuno, N.H.; Hori, N.; Takahashi, K. Primary malignant melanoma of the esophagus treated by esophagectomy and adjuvant dendritic-cell therapy. J. Gastroenterol.; 2005; 40, pp. 545-546. [DOI: https://dx.doi.org/10.1007/s00535-004-1582-8]

170. Kimura, H.; Kato, H.; Sohda, M.; Nakajima, M.; Fukai, Y.; Miyazaki, T.; Masuda, N.; Manda, R.; Fukuchi, M.; Ojima, H. et al. Flat-type primary malignant melanoma of the esophagus treated by EMR: Case report. Gastrointest. Endosc.; 2005; 61, pp. 787-789. [DOI: https://dx.doi.org/10.1016/S0016-5107(04)02840-8]

171. Suzuki, Y.; Aoyama, N.; Minamide, J.; Takata, K.; Ogata, T. Amelanotic malignant melanoma of the esophagus: Report of a patient with recurrence successfully treated with chemoendocrine therapy. Int. J. Clin. Oncol.; 2005; 10, pp. 204-207. [DOI: https://dx.doi.org/10.1007/s10147-004-0473-6] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15990972]

172. Heidemann, J.; Lebiedz, P.; Herbst, H.; Spahn, T.W.; Domagk, D.; Domschke, W.; Kucharzik, T. Amelanotic malignant melanoma of the esophagus: Case report. Z. Gastroenterol.; 2005; 43, pp. 597-600. [DOI: https://dx.doi.org/10.1055/s-2005-858102] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15986290]

173. Lin, P.W.; Lee, R.C.; Chern, M.S.; Chiang, J.H.; Chang, C.Y. Primary malignant melanoma of the esophagus. J. Chin. Med. Assoc.; 2006; 69, pp. 334-337. [DOI: https://dx.doi.org/10.1016/S1726-4901(09)70269-2]

174. Stringa, O.; Valdez, R.; Beguerie, J.R.; Abbruzzese, M.; Lioni, M.; Nadales, A.; Iudica, F.; Venditti, J.; San Roman, A. Primary amelanotic melanoma of the esophagus. Int. J. Dermatol.; 2006; 45, pp. 1207-1210. [DOI: https://dx.doi.org/10.1111/j.1365-4632.2006.02717.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17040443]

175. Okano, K.; Sugiyama, T.; Akamoto, S.; Yachida, S.; Usuki, H.; Wakabayashi, H.; Maeta, H. (18)F-FDG accumulations in primary malignant melanoma of the esophagus. Surgery; 2006; 140, pp. 118-119. [DOI: https://dx.doi.org/10.1016/j.surg.2005.06.039] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16857450]

176. Vandewoude, M.; Cornelis, A.; Wyndaele, D.; Brussaard, C.; Kums, R. (18)FDG-PET-scan in staging of primary malignant melanoma of the oesophagus: A case report. Acta Gastroenterol. Belg.; 2006; 69, pp. 12-14. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16673556]

177. Dionigi, G.; Rovera, F.; Boni, L.; Imperatori, A.; Dionigi, R. Solitary pulmonary metastasis from primary melanoma of the oesophagus 5 years after resection of the primary tumor. World J. Surg. Oncol.; 2006; 4, 22. [DOI: https://dx.doi.org/10.1186/1477-7819-4-22] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16613599]

178. De Simone, P.; Gelin, M.; El Nakadi, I. Amelanotic malignant melanoma of the esophagus. Report of a case. Minerva Chir.; 2006; 61, pp. 45-49.

179. Pruyt, M.; Devriendt, D.; Vanneste, A. Malignant melanoma and adenocarcinoma of a Barrett oesophagus. Acta Chir. Belg.; 2006; 106, pp. 616-618. [DOI: https://dx.doi.org/10.1080/00015458.2006.11679966] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17168284]

180. Li, B.; Lei, W.; Shao, K.; Zhang, C.; Chen, Z.; Shi, S.; He, J. Characteristics and prognosis of primary malignant melanoma of the esophagus. Melanoma Res.; 2007; 17, pp. 239-242. [DOI: https://dx.doi.org/10.1097/CMR.0b013e3281c4a079]

181. Kelly, J.; Leader, M.; Broe, P. Primary malignant melanoma of the oesophagus: A case report. J. Med. Case Rep.; 2007; 1, 50. [DOI: https://dx.doi.org/10.1186/1752-1947-1-50] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17629931]

182. Oshiro, T.; Shimoji, H.; Matsuura, F.; Uchima, N.; Kinjo, F.; Nakayama, T.; Nishimaki, T. Primary malignant melanoma of the esophagus arising from a melanotic lesion: Report of a case. Surg. Today; 2007; 37, pp. 671-675. [DOI: https://dx.doi.org/10.1007/s00595-006-3444-x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17643212]

183. Lee, S.A.; Hwang, J.J.; Choi, Y.H. Surgical treatment of primary malignant melanoma of the esophagus: A case report. J. Korean Med. Sci.; 2007; 22, pp. 149-152. [DOI: https://dx.doi.org/10.3346/jkms.2007.22.1.149]

184. Ho, K.Y.; Cheng, J.; Wee, A.; Soo, K.C. Primary malignant melanoma of the esophagus with multiple esophageal lesions. Nat. Clin. Pract. Gastroenterol. Hepatol.; 2007; 4, pp. 171-174. [DOI: https://dx.doi.org/10.1038/ncpgasthep0761]

185. Gerger, A.; Smolle-Jüttner, F.M.; Samonigg, H.; Wehrschütz, M.; Smolle, J. Asymptomatic primary malignant melanoma of the esophagus. Onkologie; 2007; 30, pp. 206-208. [DOI: https://dx.doi.org/10.1159/000099987]

186. Ueda, Y.; Shimizu, K.; Itoh, T.; Fuji, N.; Naito, K.; Shiozaki, A.; Yamamoto, Y.; Shimizu, T.; Iwamoto, A.; Tamai, H. et al. Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides. Jpn. J. Clin. Oncol.; 2007; 37, pp. 140-145. [DOI: https://dx.doi.org/10.1093/jjco/hyl136] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17255158]

187. Solari, N.; Acquati, M.; Queirolo, P.; Stella, M.; Di Somma, C.; Truini, M.; Cafiero, F. Primary melanoma of the esophagus with non-metastatic dark lymph nodes in a female breast cancer patient. Anticancer Res.; 2007; 27, pp. 2849-2853. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17695459]

188. Fredricks, J.R.; Bejarano, P.A. Primary malignant melanoma of the esophagus with separate foci of melanoma in situ and atypical melanocytic hyperplasia in a patient positive for human immunodeficiency virus: A case report and review of the literature. Arch. Pathol. Lab. Med.; 2008; 132, pp. 1675-1678. [DOI: https://dx.doi.org/10.5858/2008-132-1675-PMMOTE] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18834229]

189. Sanchez, A.A.; Wu, T.T.; Prieto, V.G.; Rashid, A.; Hamilton, S.R.; Wang, H. Comparison of primary and metastatic malignant melanoma of the esophagus: Clinicopathologic review of 10 cases. Arch. Pathol. Lab. Med.; 2008; 132, pp. 1623-1629. [DOI: https://dx.doi.org/10.5858/2008-132-1623-COPAMM]

190. Kanamori, N.; Igaki, H. A case of primary malignant melanoma of the esophagus. Jpn. J. Clin. Oncol.; 2008; 38, 233. [DOI: https://dx.doi.org/10.1093/jjco/hyn018] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18337320]

191. Frangi Caregnato, A.; Alvarez Martínez, D.; Montalva Orón, E.; de Juan Burgeño, M. Melanoma primario de esófago [Primary melanoma of the esophagus]. Cir. Esp.; 2008; 83, 325.(In Spanish) [DOI: https://dx.doi.org/10.1016/S0009-739X(08)70585-2]

192. Leong, Q.M.; Kam, J.H. Primary malignant melanoma of the lower oesophagus presenting with dysphagia and upper gastrointestinal bleeding. Cases J.; 2008; 1, 28. [DOI: https://dx.doi.org/10.1186/1757-1626-1-28] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18620569]

193. Lu, T.J.; Huang, T.W.; Lee, S.C. Primary malignant melanoma of the esophagus. Hematol. Oncol. Stem Cell. Ther.; 2008; 1, pp. 246-248. [DOI: https://dx.doi.org/10.1016/S1658-3876(08)50013-6]

194. Kranzfelder, M.; Seidl, S.; Dobritz, M.; Brücher, B.L. Amelanotic esophageal malignant melanoma: Case report and short review of the literature. Case Rep. Gastroenterol.; 2008; 2, pp. 224-231. [DOI: https://dx.doi.org/10.1159/000137376] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21327177]

195. Tzung-Ju, L.; Tsai-Wang, H.; Shih-Chun, L. Primary malignant melanoma of the esophagus. Ann. Saudi Med.; 2008; 28, pp. 458-460. [DOI: https://dx.doi.org/10.5144/0256-4947.2008.458]

196. Suzuki, H.; Nakanishi, Y.; Taniguchi, H.; Shimoda, T.; Yamaguchi, H.; Igaki, H.; Tachimori, Y.; Kato, H. Two cases of early-stage esophageal malignant melanoma with long-term survival. Pathol. Int.; 2008; 58, pp. 432-435. [DOI: https://dx.doi.org/10.1111/j.1440-1827.2008.02249.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18577112]

197. Kang, M.J.; Yi, S.Y. Nevus-like appearance of primary malignant melanoma of the esophagus. Gastroenterol. Res. Pract.; 2009; 2009, 285753. [DOI: https://dx.doi.org/10.1155/2009/285753] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19644559]

198. Miyatani, H.; Yoshida, Y.; Ushimaru, S.; Sagihara, N.; Yamada, S. Slow growing flat-type primary malignant melanoma of the esophagus treated with cap-assisted EMR. Dig. Endosc.; 2009; 21, pp. 255-257. [DOI: https://dx.doi.org/10.1111/j.1443-1661.2009.00902.x]

199. Zheng, Y.; Cong, C.; Su, C.; Sun, Y.; Xing, L. Epidemiology and survival outcomes of primary gastrointestinal melanoma: A SEER-based population study. Int. J. Clin. Oncol.; 2020; 25, pp. 1951-1959. [DOI: https://dx.doi.org/10.1007/s10147-020-01759-x]

200. Gupta, V.; Kochhar, R.; Sinha, S.K.; Das, A. Primary malignant melanoma of the esophagus: Long-term survival after radical resection. J. Thorac. Oncol.; 2009; 4, pp. 1180-1182. [DOI: https://dx.doi.org/10.1097/JTO.0b013e3181a8ca9f]

201. Nonoshita, T.; Shioyama, Y.; Nomoto, S.; Ohga, S.; Ohnishi, K.; Atsumi, K.; Terashima, K.; Matsuura, S.; Nakamura, K.; Hirata, H. et al. Effective palliative radiotherapy in primary malignant melanoma of the esophagus: A case report. Cases J.; 2009; 2, 6928. [DOI: https://dx.doi.org/10.4076/1757-1626-2-6928]

202. Cadili, A. Primary melanoma of the esophagus: A rare and challenging problem. South. Med. J.; 2009; 102, pp. 883-884. [DOI: https://dx.doi.org/10.1097/SMJ.0b013e3181a90b2f] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19668054]

203. Zhuang, Y.Z.; Zhang, Z.Y.; Liao, Y.Q. [Primary malignant melanoma of esophagus: Report of a case]. Zhonghua Bing Li Xue Za Zhi.; 2009; 38, pp. 60-61. (In Chinese) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19489230]

204. Yang, X.; Qu, J.; Wang, S. Primary malignant melanoma of the esophagus. Melanoma Res.; 2010; 20, pp. 59-60. [DOI: https://dx.doi.org/10.1097/CMR.0b013e3283307c8a] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20010440]

205. Yu, H.; Huang, X.Y.; Li, Y.; Xie, X.; Zhou, J.L.; Zhang, L.J.; Fu, J.H.; Wang, X. Primary malignant melanoma of the esophagus: A study of clinical features, pathology, management and prognosis. Dis. Esophagus; 2011; 24, pp. 109-113. [DOI: https://dx.doi.org/10.1111/j.1442-2050.2010.01111.x]

206. Fujii, K.; Goto, A.; Matsunaga, Y.; Hasegawa, Y.; Sukawa, Y.; Suzuki, K.; Yonezawa, K.; Abe, T.; Itoh, A.; Shinomura, Y. et al. Primary malignant melanoma of the esophagus—Detection of circulating tumor cells. Gan To Kagaku Ryoho; 2010; 37, pp. 1539-1543. (In Japanese)

207. Minami, H.; Inoue, H.; Satodate, H.; Hamatani, S.; Shin-Ei, K. A case of primary malignant melanoma in situ in the esophagus. Gastrointest. Endosc.; 2011; 73, pp. 814-815. [DOI: https://dx.doi.org/10.1016/j.gie.2010.10.001]

208. Frieling, T.; Heise, J.; Hemmerlein, B. Image of the month. Primary malignant melanoma of the esophagus. Clin. Gastroenterol. Hepatol.; 2010; 8, A22. [DOI: https://dx.doi.org/10.1016/j.cgh.2010.03.019]

209. Iwanuma, Y.; Tomita, N.; Amano, T.; Isayama, F.; Tsurumaru, M.; Hayashi, T.; Kajiyama, Y. Current status of primary malignant melanoma of the esophagus: Clinical features, pathology, management and prognosis. J. Gastroenterol.; 2012; 47, pp. 21-28. [DOI: https://dx.doi.org/10.1007/s00535-011-0490-y]

210. Bisceglia, M.; Perri, F.; Tucci, A.; Tardio, M.; Panniello, G.; Vita, G.; Pasquinelli, G. Primary malignant melanoma of the esophagus: A clinicopathologic study of a case with comprehensive literature review. Adv. Anat. Pathol.; 2011; 18, pp. 235-252. [DOI: https://dx.doi.org/10.1097/PAP.0b013e318216b99b]

211. Machado, J.; Ministro, P.; Araújo, R.; Cancela, E.; Castanheira, A.; Silva, A. Primary malignant melanoma of the esophagus: A case report. World J. Gastroenterol.; 2011; 17, pp. 4734-4738. [DOI: https://dx.doi.org/10.3748/wjg.v17.i42.4734] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22180718]

212. Kim, S.G. Primary malignant melanoma of the esophagus. Korean J. Gastroenterol.; 2011; 57, pp. 262-264. (In Korean) [DOI: https://dx.doi.org/10.4166/kjg.2011.57.4.262] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21519182]

213. Tipirneni, E.; Gunaratnam, N.T.; Tworek, J.A.; Kodali, S. Primary malignant melanoma of esophagus treated with endoscopic mucosal resection and esophagectomy. J. Gastrointest. Cancer; 2011; 42, pp. 266-268. [DOI: https://dx.doi.org/10.1007/s12029-010-9231-3]

214. Dennis, K.L.; Thomas, P.A.; Fan, F.; Olyaee, M. Primary malignant melanoma of the esophagus: A rare entity diagnosed by endoscopic ultrasound guided fine-needle aspiration. Diagn. Cytopathol.; 2012; 40, pp. 462-465. [DOI: https://dx.doi.org/10.1002/dc.21674]

215. Kumagai, Y.; Miura, K.; Nishida, T.; Igari, K.; Ochiai, T.; Iida, M.; Yamazaki, S.; Odajima, H.; Kawano, T.; Takubo, K. Simultaneous resection of metastatic melanoma in the esophagus and primary cutaneous melanoma showing partial regression: Report of a case. Surg. Today; 2012; 42, pp. 884-890. [DOI: https://dx.doi.org/10.1007/s00595-011-0101-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22179796]

216. Matsushima, Y.; Kawabata, R.; Imamura, H.; Kishimoto, T.; Yamamoto, T.; Takemoto, H.; Fukunaga, M.; Ohsato, H.; Furukawa, H.; Munakata, S. [A case of malignant melanoma of the esophagus]. Gan To Kagaku Ryoho; 2011; 38, pp. 2423-2425. (In Japanese) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22202401]

217. Malik, A.; Bansil, S.; Junglee, N.; Sutton, J.; Gasem, J.; Ahmed, W. Synchronous primary oesophageal malignant melanoma and sigmoid adenocarcinoma. BMJ Case Rep.; 2011; 2011, bcr0320114034. [DOI: https://dx.doi.org/10.1136/bcr.03.2011.4034]

218. Motoyama, S.; Maruyama, K.; Sato, Y.; Shibuya, K.; Usami, S.; Yoshino, K.; Nakatsu, T.; Nanjo, H.; Kamata, S.; Ogawa, J. A case of recurrent malignant melanoma of esophagus responsive to combined chemotherapy, radiotherapy and cellular immunotherapy. Gan To Kagaku Ryoho; 2011; 38, pp. 639-642. (In Japanese)

219. Inadomi, K.; Ishimoto, T.; Watanabe, M.; Iwatsuki, M.; Arima, K.; Ida, S.; Nagai, Y.; Iwagami, S.; Baba, Y.; Sakamoto, Y. et al. Primary malignant melanoma of the esophagus with extensive intraepithelial extension. Ann. Thorac. Surg.; 2012; 94, pp. 2105-2107. [DOI: https://dx.doi.org/10.1016/j.athoracsur.2012.04.127]

220. Cardeña, R.; Yep-Gamarra, V.; Donet-Mostacero, J.; Rodas, J. Melanoma primario del esófago [Primary melanoma of the esophagus]. Rev. Gastroenterol. Peru; 2012; 32, pp. 303-308. (In Spanish)

221. Suárez Aliaga, B.; Fernández Fernández, S. Melanoma primario multicéntrico de esófago [Multicentric primary melanoma of the esophagus]. Radiologia; 2013; 55, pp. 457-458. (In Spanish) [DOI: https://dx.doi.org/10.1016/j.rx.2011.12.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22516828]

222. Wang, S.; Tachimori, Y.; Hokamura, N.; Igaki, H.; Kishino, T.; Kushima, R. Diagnosis and surgical outcomes for primary malignant melanoma of the esophagus: A single-center experience. Ann. Thorac. Surg.; 2013; 96, pp. 1002-1006. [DOI: https://dx.doi.org/10.1016/j.athoracsur.2013.04.072] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23810175]

223. Arora, A.; Javed, A.; Agarwal, A.K. Primary Malignant Melanoma of the Esophagus. Oman. Med. J.; 2013; 28, e040. [DOI: https://dx.doi.org/10.5001/omj.2013.20] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31435466]

224. Yonal, O.; Ibrisim, D.; Songur, Y.; Cakaloglu, Y.; Tuncer, K.; Kirimlioglu, H.; Ozdil, S. Primary malignant melanoma of the esophagus. Case Rep. Gastroenterol.; 2013; 7, pp. 272-276. [DOI: https://dx.doi.org/10.1159/000353637] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23898233]

225. Kato, T.; Harano, M.; Ono, S.; Sato, D.; Choda, Y.; Kanazawa, T.; Matsukawa, H.; Ojima, Y.; Hamada, M.; Shiozaki, S. et al. A case of superficial primary malignant melanoma of the esophagus. Gan To Kagaku Ryoho; 2013; 40, pp. 2109-2111. (In Japanese)

226. Morita, F.H.; Ribeiro, U.; Sallum, R.A.A.; Tacconi, M.R.; Takeda, F.R.; da Rocha, J.R.; Ligabó Gde, S.; de Melo, E.S.; Pollara, W.M.; Cecconello, I. Primary malignant melanoma of the esophagus: A rare and aggressive disease. World J. Surg. Oncol.; 2013; 11, 210. [DOI: https://dx.doi.org/10.1186/1477-7819-11-210]

227. Sim, Y.; Teo, J.S.; Iqbal, J.; Chan, W.H. Primary melanoma of the esophagus, a diagnostic challenge. Asian J. Surg.; 2015; 38, pp. 236-238. [DOI: https://dx.doi.org/10.1016/j.asjsur.2012.11.001]

228. Zhang, L.; Ma, W.; Li, Y. Huge primary malignant melanoma of the esophagus: A case report and literature review. Thorac. Cancer.; 2013; 4, pp. 479-483. [DOI: https://dx.doi.org/10.1111/1759-7714.12063]

229. Lu, M.L.; Huang, H.; Chang, J.; Li, W.H.; Zhao, G.F.; He, H.Y.; Tang, P.; Zheng, M.Y.; Niu, Y.C.; Fu, W. Primary malignant melanoma of the esophagus: Misdiagnosis and review of literature. Rev. Esp. Enferm. Dig.; 2013; 105, pp. 488-489. [DOI: https://dx.doi.org/10.4321/s1130-01082013000800008]

230. Yang, L.; Sun, X.; Meng, X. A case of primary malignant melanoma of the esophagus. Dig. Dis. Sci.; 2013; 58, pp. 3634-3636. [DOI: https://dx.doi.org/10.1007/s10620-013-2780-0]

231. Wu, I.C.; Lee, J.Y.; Wu, C.C. A rare but unique tumor in the esophagus. Primary esophageal melanoma. Gastroenterology; 2013; 144, pp. 856-857. [DOI: https://dx.doi.org/10.1053/j.gastro.2012.11.004] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23439234]

232. Hu, Y.M.; Yan, J.D.; Gao, Y.; Xia, Q.A.; Wu, Y.; Zhang, Z.Y. Primary malignant melanoma of esophagus: A case report and review of literature. Int. J. Clin. Exp. Pathol.; 2014; 7, pp. 8176-8180. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25550869]

233. Sabat, J.; Mannan, R.; Legasto, A.; Connery, C. Long-term survivor of primary malignant melanoma of the esophagus treated with surgical resection. Int. J. Surg. Case Rep.; 2015; 6C, pp. 182-185. [DOI: https://dx.doi.org/10.1016/j.ijscr.2014.12.016]

234. Li, Y.H.; Li, X.; Zou, X.P. Primary malignant melanoma of the esophagus: A case report. World J. Gastroenterol.; 2014; 20, pp. 2731-2734. [DOI: https://dx.doi.org/10.3748/wjg.v20.i10.2731] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24627611]

235. Yu, Q.; Yuan, S. Primary malignant melanoma of the esophagus with subtotal esophagectomy: A case report. Int. J. Clin. Exp. Med.; 2014; 7, pp. 4519-4522.

236. Pun, A.H.; Devitt, P.G. Primary malignant melanoma of the oesophagus: Two case reports. J. Surg. Case Rep.; 2014; 2014, rju005. [DOI: https://dx.doi.org/10.1093/jscr/rju005]

237. Izumi, D.; Ishimoto, T.; Yoshida, N.; Nakamura, K.; Kosumi, K.; Tokunaga, R.; Sugihara, H.; Sawayama, H.; Karashima, R.; Imamura, Y. et al. A clinicopathological analysis of primary mucosal malignant melanoma. Surg. Today; 2015; 45, pp. 886-891. [DOI: https://dx.doi.org/10.1007/s00595-014-1041-y]

238. Zheng, J.; Mo, H.; Ma, S.; Wang, Z. Clinicopathological findings of primary esophageal malignant melanoma: Report of six cases and review of literature. Int. J. Clin. Exp. Pathol.; 2014; 7, pp. 7230-7235.

239. Choudhary, N.S.; Puri, R.; Goel, R.; Sud, R. Primary malignant melanoma involving the whole esophagus: A rare case with rarer presentation. Endoscopy; 2014; 46, pp. E621-E622. [DOI: https://dx.doi.org/10.1055/s-0034-1390783]

240. Abdel Samie, A.; Stumpf, M.; Fayyazi, A.; Werle, S.; Theilmann, L. Primary multifocal malignant melanoma of the esophagus. J. Gastrointest. Cancer; 2014; 45, pp. 228-230. [DOI: https://dx.doi.org/10.1007/s12029-013-9503-9]

241. Isozaki, T.; Yamada, S.; Shiomi, M.; Yasuda, S.; Kamada, T.; Tsujii, H.; Matsubara, H. [Heavy ion radiotherapy for recurrence of an esophageal primary malignant melanoma]. Gan. To Kagaku Ryoho.; 2014; 41, pp. 2387-2389. (In Japanese)

242. Navarro-Ballester, A.; De Lazaro-De Molina, S.; Gaona-Morales, J. Primary Malignant Melanoma of the Esophagus: A Case Report and Review of the Literature. Am. J. Case Rep.; 2015; 16, pp. 491-495. [DOI: https://dx.doi.org/10.12659/A.J.C.R.894041] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26212619]

243. Jora, C.; Pankaj, P.; Verma, R.; Jain, A.; Belho, E.S. Primary malignant melanoma of the esophagus. Indian J. Nucl. Med.; 2015; 30, pp. 162-164. [DOI: https://dx.doi.org/10.4103/0972-3919.152983]

244. Jiang, W.; Zou, Z.; Liu, B. Primary malignant melanoma of the esophagus: A case report and review of the literature. Oncol. Lett.; 2015; 9, pp. 2036-2040. [DOI: https://dx.doi.org/10.3892/ol.2015.3014]

245. Yamamoto, S.; Makuuchi, H.; Kumaki, N.; Ozawa, S.; Shimada, H.; Chino, O.; Kazuno, A.; Yasuda, S.; Tamayama, T.; Sakai, I. A Long Surviving Case of Multiple Early Stage Primary Malignant Melanoma of the Esophagus and a Review of the Literature. Tokai J. Exp. Clin. Med.; 2015; 40, pp. 90-95.

246. Revilla Morato, C.; Mora Soler, A.; Prieto Bermejo, A.B.; Piñero Pérez, C.; Pérez Corte, D.; Acosta Materán, R.; Marcos Prieto, H.; Gimeno Mateos, L.I.; Geijo Martínez, F.; Rodriguez Pérez, A. Melanoma maligno primario esofágico: Una causa infrecuente de disfagia [Primary malignant melanoma of the esophagus: A rare cause of dysphagia]. Gastroenterol Hepatol.; 2016; 39, pp. 47-48. (In Spanish) [DOI: https://dx.doi.org/10.1016/j.gastrohep.2015.04.001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25979435]

247. Harada, K.; Mine, S.; Yamada, K.; Shigaki, H.; Oya, S.; Baba, H.; Watanabe, M. Long-term outcome of esophagectomy for primary malignant melanoma of the esophagus: A single-institute retrospective analysis. Dis. Esophagus; 2016; 29, pp. 314-319. [DOI: https://dx.doi.org/10.1111/dote.12331]

248. Wallis, G.; Sehgal, V.; Haider, A.; Bridgewater, J.; Novelli, M.; Dawas, K.; Haidry, R. Primary malignant melanoma of the esophagus. Endoscopy; 2015; 47, pp. E81-E82. [DOI: https://dx.doi.org/10.1055/s-0034-1391126] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25926226]

249. Dikmen, K.; Ferahkose, Z.; Turhan, B.; Caliskan, G.T.; Bostanci, H.; Buyukkasap, C.; Keceoglu, S.; Aytac, B. Concurrence of primary malignant melanoma of the esophagus with adenocarcinoma of sigmoid colon and villous adenoma of cecum: A case presentation. Int. J. Clin. Exp. Med.; 2015; 8, pp. 16793-16797.

250. Rathi, P.M.; Gautam, S.; Sharma, S. Primary Maligant Melanoma of the Oesophagus. J. Assoc. Physicians India; 2015; 63, pp. 74-75.

251. Liu, H.; Yan, Y.; Jiang, C.M. Primary Malignant Melanoma of the Esophagus with Unusual Endoscopic Findings: A Case Report and Literature Review. Medicine; 2016; 95, e3479. [DOI: https://dx.doi.org/10.1097/MD.0000000000003479] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27124046]

252. Rawandale, N.A.; Suryawanshi, K.H. Primary Spindle Cell Malignant Melanoma of Esophagus: An Unusual Finding. J. Clin. Diagn Res.; 2016; 10, pp. OD03-OD04. [DOI: https://dx.doi.org/10.7860/JCDR/2016/16121.7188] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27042502]

253. Wang, M.; Chen, J.; Sun, K.; Zhuang, Y.; Xu, F.; Xu, B.; Zhang, H.; Li, Q.; Zhang, D. Primary malignant melanoma of the esophagus treated by endoscopic submucosal dissection: A case report. Exp. Ther. Med.; 2016; 12, pp. 1319-1322. [DOI: https://dx.doi.org/10.3892/etm.2016.3482] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27602062]

254. Gao, S.; Li, J.; Feng, X.; Shi, S.; He, J. Characteristics and Surgical Outcomes for Primary Malignant Melanoma of the Esophagus. Sci. Rep.; 2016; 6, 23804. [DOI: https://dx.doi.org/10.1038/srep23804]

255. Ueyama, H.; Yao, T.; Matsumoto, K.; Nakagawa, Y.; Takeda, T.; Matsumoto, K.; Nagahara, A.; Watanabe, S. Flat-type primary malignant melanoma of the esophagus. Endosc. Int. Open; 2016; 4, pp. E687-E689. [DOI: https://dx.doi.org/10.1055/s-0042-106205]

256. Granel Villach, L.; Moya Sanz, M.A.; Fortea Sanchis, C.; Escrig Sos, V.J.; Fortea Sanchís, C.; Martínez Lahuerta, C.; Tornador Gaya, N.; Salvador Sanchís, J.L. Primary esophageal melanoma: Report of a case. Rev. Esp. Enferm. Dig.; 2016; 108, pp. 666-669. [DOI: https://dx.doi.org/10.17235/reed.2016.3908/2015]

257. Zhou, Y.B.; Yuan, Y.; Hu, B.; Che, G.W. Image of the Month: Primary Multifocal Malignant Melanoma of Esophagus Co-Occurs with Esophagogastric Junction Adenocarcinoma. Am. J. Gastroenterol.; 2016; 111, 312. [DOI: https://dx.doi.org/10.1038/ajg.2015.252]

258. Inadomi, K.; Kumagai, H.; Arita, S.; Tsuruta, N.; Takayoshi, K.; Mishima, K.; Ota, S.I.; Tanaka, M.; Okumura, Y.; Sagara, K. et al. Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report. Medicine; 2016; 95, e4283. [DOI: https://dx.doi.org/10.1097/MD.0000000000004283]

259. Kuwabara, S.; Ebihara, Y.; Nakanishi, Y.; Asano, T.; Noji, T.; Kurashima, Y.; Murakami, S.; Nakamura, T.; Tsuchikawa, T.; Okamura, K. et al. Primary malignant melanoma of the esophagus treated with subtotal esophagectomy: A case report. BMC Surg.; 2017; 17, 122. [DOI: https://dx.doi.org/10.1186/s12893-017-0326-7]

260. Imai, S.; Suzuki, A.; Yamamoto, Y.; Koyama, M.; Sugiyama, S.; Kitazawa, M.; Miyagawa, Y.; Miyagawa, S. Primary malignant melanoma of esophagus following chemoradiotherapy for esophageal squamous cell carcinoma: Report of a case. Clin. J. Gastroenterol.; 2017; 10, pp. 336-341. [DOI: https://dx.doi.org/10.1007/s12328-017-0751-2]

261. Sun, H.; Gong, L.; Zhao, G.; Zhan, H.; Meng, B.; Yu, Z.; Pan, Z. Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus. J Surg Oncol.; 2018; 117, pp. 588-596. [DOI: https://dx.doi.org/10.1002/jso.24905] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29266237]

262. Li, J.; Yan, S.; Liu, Z.; Zhou, Y.; Pan, Y.; Yuan, W.; Liu, M.; Tan, Q.; Tian, G.; Dong, B. et al. Multiregional Sequencing Reveals Genomic Alterations and Clonal Dynamics in Primary Malignant Melanoma of the Esophagus. Cancer Res.; 2018; 78, pp. 338-347. [DOI: https://dx.doi.org/10.1158/0008-5472.CAN-17-0938] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28972077]

263. Ohnuma, H.; Ishikawa, K.; Hirakawa, M.; Kikuchi, S.; Sato, Y.; Miyanishi, K.; Kato, J. Cases of primary malignant melanoma and melanocytosis of the esophagus observed by magnifying endoscopy: Application to differential diagnosis: Case series. Medicine; 2017; 96, e6701. [DOI: https://dx.doi.org/10.1097/MD.0000000000006701] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28445275]

264. Fukuda, S.; Ito, H.; Ohba, R.; Sato, Y.; Ohyauchi, M.; Igarashi, T.; Obana, N.; Iijima, K. A Retrospective Study, an Initial Lesion of Primary Malignant Melanoma of the Esophagus Revealed by Endoscopy. Intern. Med.; 2017; 56, pp. 2133-2137. [DOI: https://dx.doi.org/10.2169/internalmedicine.8378-16]

265. Katerji, H.; Childs, J.M.; Bratton, L.E.; Peyre, C.G.; Huber, A.R. Primary Esophageal Melanoma with Aberrant CD56 Expression: A Potential Diagnostic Pitfall. Case Rep. Pathol.; 2017; 2017, 9052637. [DOI: https://dx.doi.org/10.1155/2017/9052637] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29230340]

266. Weiner, J.P.; Shao, M.; Schwartz, D.; Wong, A.; Schreiber, D. Patterns of care and survival outcomes in the treatment of esophageal melanoma. Dis. Esophagus; 2017; 30, 6. [DOI: https://dx.doi.org/10.1111/dote.12504]

267. Krauthammer, M. Unraveling the etiology of primary malignant melanoma of the esophagus. J. Thorac. Dis.; 2018; 10, pp. S1074-S1075. [DOI: https://dx.doi.org/10.21037/jtd.2018.03.91] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29850187]

268. Ling, C.; Feng, J.; Li, J.; Liu, Q. Primary malignant melanoma of the esophagus. Turk. J. Gastroenterol.; 2018; 29, pp. 711-713. [DOI: https://dx.doi.org/10.5152/tjg.2018.18065]

269. Sasaki, K.; Uchikado, Y.; Omoto, I.; Amatatsu, M.; Megumi, K.; Okumura, H.; Maemura, K.; Natsugoe, S. Multidisciplinary therapy for metastatic primary malignant melanoma of the esophagus: A case report. Mol. Clin. Oncol.; 2018; 8, pp. 528-532. [DOI: https://dx.doi.org/10.3892/mco.2018.1572]

270. Li, J.; Yan, S.; Wu, N. Primary malignant melanoma of esophagus shared similar genetic characters with both cutaneous and oral mucosal melanoma. J. Thorac. Dis.; 2018; 10, pp. S2095-S2096. [DOI: https://dx.doi.org/10.21037/jtd.2018.05.158]

271. Kobayashi, J.; Fujimoto, D.; Murakami, M.; Hirono, Y.; Goi, T. A report of amelanotic malignant melanoma of the esophagus diagnosed appropriately with novel markers: A case report. Oncol. Lett.; 2018; 15, pp. 9087-9092. [DOI: https://dx.doi.org/10.3892/ol.2018.8479] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29844820]

272. Koga, N.; Kubo, N.; Saeki, H.; Sasaki, S.; Jogo, T.; Hirose, K.; Nakashima, Y.; Oki, E.; Koga, Y.; Oda, Y. et al. Primary amelanotic malignant melanoma of the esophagus: A case report. Surg. Case Rep.; 2019; 5, 4. [DOI: https://dx.doi.org/10.1186/s40792-019-0564-2] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30635729]

273. Zhang, R.X.; Li, Y.Y.; Liu, C.J.; Wang, W.N.; Cao, Y.; Bai, Y.H.; Zhang, T.J. Advanced primary amelanotic malignant melanoma of the esophagus: A case report. World J. Clin. Cases; 2019; 7, pp. 3160-3167. [DOI: https://dx.doi.org/10.12998/wjcc.v7.i19.3160] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31624769]

274. Matsumoto, Y.; Hirasawa, S.; Natsume, T.; Kainuma, O.; Tanaka, H.; Toyozumi, T.; Murakami, K.; Matsubara, H.; Maruyama, T. A Case of Primary Amelanotic Malignant Melanoma of the Esophagus, Wherein Pseudoprogression Was Suspected during Immune Checkpoint Inhibitor Treatment. Gan To Kagaku Ryoho.; 2020; 47, pp. 1251-1253. (In Japanese) [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32829366]

275. Tsukamoto, R.; Ihara, H.; Takase, M.; Shimazu, A.; Takei, M.; Miura, H.; Sakamoto, K.; Namekata, K. Immunotherapy against esophageal primary amelanotic malignant melanoma relapse. J. Surg. Case Rep.; 2021; 2021, rjab393. [DOI: https://dx.doi.org/10.1093/jscr/rjab393] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34659737]

276. Wang, X.; Kong, Y.; Chi, Z.; Sheng, X.; Cui, C.; Mao, L.; Lian, B.; Tang, B.; Yan, X.; Si, L. et al. Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients. Thorac. Cancer.; 2019; 10, pp. 950-956. [DOI: https://dx.doi.org/10.1111/1759-7714.13034]

277. Nakamura, K.; Urabe, Y.; Oka, S.; Ito, M.; Kotachi, T.; Ninomiya, Y.; Boda, T.; Hiyama, T.; Emi, M.; Hamai, Y. et al. A case of primary malignant melanoma of the esophagus with a widely expanded surface area. Clin. J. Gastroenterol.; 2019; 12, pp. 424-428. [DOI: https://dx.doi.org/10.1007/s12328-019-00961-3]

278. Lasota, J.; Kowalik, A.; Felisiak-Golabek, A.; Zięba, S.; Waloszczyk, P.; Masiuk, M.; Wejman, J.; Szumilo, J.; Miettinen, M. Primary malignant melanoma of esophagus: Clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors. Mod. Pathol.; 2019; 32, pp. 957-966. [DOI: https://dx.doi.org/10.1038/s41379-018-0163-y] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30760858]

279. Li, J.; Liu, Y.; Wang, B.; Sun, X.; Meng, X. Malignant melanoma of the esophagus complicated with poorly differentiated mucinous adenocarcinoma of the stomach: A case report. Medicine; 2019; 98, e14783. [DOI: https://dx.doi.org/10.1097/MD.0000000000014783] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30855489]

280. Yamai, D.; Ichikawa, H.; Kano, Y.; Hanyu, T.; Ishikawa, T.; Usui, K.; Nemoto, M.; Hirose, Y.; Miura, K.; Nagahashi, M. et al. A Case of Esophageal Primary Malignant Melanoma That Developed During the Follow-Up of Esophageal Melanocytosis. Gan To Kagaku Ryoho; 2019; 46, pp. 2012-2014. (In Japanese)

281. Cheng, L.; Guo, Z.Y.; Lei, L.; Wang, W.X.; Xu, C.W.; Fang, M.Y. Treatment and prognosis of primary malignant melanoma of the esophagus. Transl. Cancer Res.; 2020; 9, pp. 4141-4147. [DOI: https://dx.doi.org/10.21037/tcr-19-2349]

282. Chen, H.; Fu, Q.; Sun, K. Characteristics and prognosis of primary malignant melanoma of the esophagus. Medicine; 2020; 99, e20957. [DOI: https://dx.doi.org/10.1097/MD.0000000000020957] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32664098]

283. Iwasaki, K.; Ota, Y.; Yamada, E.; Takahashi, K.; Watanabe, T.; Makuuchi, Y.; Suda, T.; Osaka, Y.; Seshimo, A.; Katsumata, K. et al. Primary malignant melanoma of the esophagus with multiple lymph node metastases: A case report and literature review. Medicine; 2020; 99, e18573. [DOI: https://dx.doi.org/10.1097/MD.0000000000018573]

284. Sanlorenzo, M.; Ribero, S.; Osella Abate, S.; Mariani, S.; Strignano, P.; Salizzoni, M.; Savoia, P.; Fierro, M.T.; Quaglino, P. Genetic mutations in primary malignant melanoma of the esophagus: Case report and literature review. G. Ital. Dermatol. Venereol.; 2020; 155, pp. 680-682. [DOI: https://dx.doi.org/10.23736/S0392-0488.16.05174-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33295742]

285. Dai, L.; Wang, Z.M.; Xue, Z.Q.; He, M.; Yuan, Y.; Shang, X.Q.; Chen, K.N. Chinese Cooperative Primary Malignant Melanoma of the Esophagus Group (CCPMMEG). Results of surgical treatment for primary malignant melanoma of the esophagus: A multicenter retrospective study. J. Thorac. Cardiovasc. Surg.; 2020; 161, pp. 294-302. [DOI: https://dx.doi.org/10.1016/j.jtcvs.2020.03.006]

286. Li, J.; Li, X.; Song, Q.Y.; Ge, Q.Y.; Zhang, Z.H. Primary malignant melanoma of esophagus: A clinicopathological analysis of 6 cases. Zhonghua Bing Li Xue Za Zhi; 2020; 49, pp. 1317-1319. (In Chinese) [DOI: https://dx.doi.org/10.3760/cma.j.cn112151-20200319-00235] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33287522]

287. Hussein Agha, Y.; Parker, N.A.; Alderson, J. Case Report: Primary melanoma of the gastroesophageal junction. F1000Research; 2020; 9, 490. [DOI: https://dx.doi.org/10.12688/f1000research.24302.1] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32724562]

288. Dey, S.; Rosero, D.S.; Chotai, A. Primary Melanoma of Esophagus Mimicking a Carcinoma. Arch. Iran. Med.; 2020; 23, pp. 56-58. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31910636]

289. Weskamp, A.L.; Hudspath, C.B.; Tritsch, A.M. Primary Malignant Melanoma of the Esophagus Presenting as Chronic Cough. ACG Case Rep. J.; 2021; 8, e00645. [DOI: https://dx.doi.org/10.14309/crj.0000000000000645] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34423064]

290. Endo, F.; Akiyama, Y.; Onishi, M.; Fujisawa, R.; Sasaki, N.; Nikai, H.; Baba, S.; Sugimoto, R.; Kimura, T.; Takahara, T. et al. Primary esophageal malignant melanoma successfully treated with anti-PD-1 antibody for retroperitoneal recurrence after esophagectomy: A case report. Int. J. Surg. Case Rep.; 2020; 75, pp. 152-156. [DOI: https://dx.doi.org/10.1016/j.ijscr.2020.09.034]

291. Ito, S.; Tachimori, Y.; Terado, Y.; Sakon, R.; Narita, K.; Goto, M. Primary malignant melanoma of the esophagus successfully treated with nivolumab: A case report. J. Med. Case Rep.; 2021; 15, 237. [DOI: https://dx.doi.org/10.1186/s13256-021-02821-6]

292. Chu, Y.M.; Hung, C.S.; Huang, C.S. Primary malignant melanoma of the esophagogastric junction: A case report. Medicine; 2021; 100, e26467. [DOI: https://dx.doi.org/10.1097/MD.0000000000026467] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34160452]

293. Yamaguchi, T.; Fushida, S.; Kinoshita, J.; Saito, H.; Shimada, M.; Terai, S.; Moriyama, H.; Okamoto, K.; Nakamura, K.; Ninomiya, I. et al. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration. Surg. Case Rep.; 2021; 7, 253. [DOI: https://dx.doi.org/10.1186/s40792-021-01336-y] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34882298]

294. Zhao, T.; Kong, F.W.; Wang, H.; Liu, D.; Wang, C.Y.; Luo, J.H.; Zhang, M.; Wu, W.B. A long-term survivor with esophageal melanoma and pulmonary metastasis after single-stage esophagectomy and lobectomy: Case report and literature review. Medicine; 2017; 96, e7003. [DOI: https://dx.doi.org/10.1097/MD.0000000000007003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28538413]

295. Board, R.; Smittenaar, R.; Lawton, S.; Liu, H.; Juwa, B.; Chao, D.; Corrie, P. Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018. Int. J. Cancer; 2021; 148, pp. 868-875. [DOI: https://dx.doi.org/10.1002/ijc.33266] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32838478]

296. Okamoto, T.; Nakano, E.; Yamauchi, T. Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: A case report. J. Med. Case Rep.; 2021; 15, 345. [DOI: https://dx.doi.org/10.1186/s13256-021-02928-w]

297. Meng, H.; Zhao, X.K.; Song, X.; Han, W.L.; Zhou, S.L.; Sun, L.; Hu, S.J.; Cheng, R.; Wang, M.; Yin, Y.H. et al. Clinical pathological features of 180 cases with primary esophageal malignant melanoma. Zhonghua Zhong Liu Za Zhi; 2021; 43, pp. 949-954. (In Chinese) [DOI: https://dx.doi.org/10.3760/cma.j.cn112152-20191028-00692]

298. Tang, Y.; Jiang, M.; Hu, X.; Chen, C.; Huang, Q. Difficulties encountered in the diagnosis of primary esophageal malignant melanoma by 18F-fluorodeoxyglucose positron emission tomography/computed tomography: A case report. Ann. Palliat. Med.; 2021; 10, pp. 4975-4981. [DOI: https://dx.doi.org/10.21037/apm-21-649]

299. Karapiperis, D.; Vrakas, S.; Ignatova, S.; Tribonias, G.; Franzen, T. Primary malignant melanoma of the esophagus. Clin. Case Rep.; 2022; 10, e05660. [DOI: https://dx.doi.org/10.1002/ccr3.5660]

300. Kashfi, S.; Marneni, N.; Sharma, S.; Vigoda, I. Primary Malignant Melanoma of the Esophagus in a 76-Year-Old Female. Cureus; 2022; 14, e23250. [DOI: https://dx.doi.org/10.7759/cureus.23250]

301. Stępień, K.; Skorek, P.; Włodarczyk, J.; Wójcik, J.; Smęder, T.; Trybalski, Ł.; Rudnicka-Sosin, L.; Kużdżał, J.; Kocoń, P. Various clinical scenarios of primary melanoma of the esophagus: A retrospective 20-year analysis from two university thoracic surgery centers. Adv. Clin. Exp. Med.; 2022; 31, pp. 337-344. [DOI: https://dx.doi.org/10.17219/acem/146797] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35349229]

302. Kim, T.S.; Min, B.H.; Min, Y.W.; Lee, H.; Rhee, P.L.; Kim, J.J.; Lee, J.H. Clinical characteristics and treatment outcomes of primary malignant melanoma of esophagus: A single center experience. BMC Gastroenterol.; 2022; 22, 157. [DOI: https://dx.doi.org/10.1186/s12876-022-02235-8] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35351022]

303. Williams, E.; Bolger, J.C.; Darling, G. Radical Resection in an Era of Immune Therapy for Primary Esophageal Melanoma. Ann. Thorac. Surg.; 2022; ahead of print [DOI: https://dx.doi.org/10.1016/j.athoracsur.2022.01.063]

304. Tsuyama, S.; Kohsaka, S.; Hayashi, T.; Suehara, Y.; Hashimoto, T.; Kajiyama, Y.; Tsurumaru, M.; Ueno, T.; Mano, H.; Yao, T. et al. Comprehensive clinicopathological and molecular analysis of primary malignant melanoma of the oesophagus. Histopathology; 2021; 78, pp. 240-251. [DOI: https://dx.doi.org/10.1111/his.14210] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32654197]

305. Rochefort, P.; Roussel, J.; de la Fouchardière, A.; Sarabi, M.; Desseigne, F.; Guibert, P.; Cattey-Javouhey, A.; Mastier, C.; Neidhardt-Berard, E.M.; de la Fouchardière, C. Primary malignant melanoma of the esophagus, treated with immunotherapy: A case report. Immunotherapy; 2018; 10, pp. 831-835. [DOI: https://dx.doi.org/10.2217/imt-2018-0011] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30073896]

306. Hashimoto, T.; Makino, T.; Yamasaki, M.; Tanaka, K.; Miyazaki, Y.; Takahashi, T.; Kurokawa, Y.; Motoori, M.; Kimura, Y.; Nakajima, K. et al. Clinicopathological characteristics and survival of primary malignant melanoma of the esophagus. Oncol. Lett.; 2019; 18, pp. 1872-1880. [DOI: https://dx.doi.org/10.3892/ol.2019.10519]